Document:

Exhibit
4.1

 

Execution
Copy

 

arrangement
agreement

 

BY
AND AMONG

 

INTERCURE
LTD.,

 

CANNDOC
ACQUISITION SUBCO LTD.,

 

subversive
REAL ESTATE acquisition REIT LP, 

 

SUBVERSIVE
REAL ESTATE ACQUISITION REIT (GP) Inc., and

 

SUBVERSIVE
REAL ESTATE SPONSOR LLC,

 

As
Representative

 

DATED
AS OF FEBRUARY 9, 2021

 

    	 

     

    

 

Table
of Contents

 

	 	Page
	 	 
	ARTICLE
    1 INTERPRETATION	2
	 	 	 
	1.1	Definitions	2
	1.2	Amendment
    and Restatement	12
	1.3	Singular,
    Plural, etc.	12
	1.4	Deemed
    Currency	12
	1.5	Headings,
    etc.	13
	1.6	Date
    for any Action	13
	1.7	Governing
    Law	13
	1.8	Attornment	13
	1.9	Schedules
    and Exhibits	13
	 	 	 
	ARTICLE
    2 THE BUSINESS COMBINATION	13
	 	 	 
	2.1	Business
    Combination Steps	13
	2.2	Implementation
    Covenants	15
	2.3	Board
    of Directors and Senior Officers	18
	 	 	 
	ARTICLE
    3 ARRANGEMENT	19
	 	 	 
	3.1	The
    Arrangement	19
	3.2	The
    Interim Order	19
	3.3	The
    Company Meeting; Information Circular	20
	3.4	The
    Final Order	21
	3.5	Court
    Proceedings	21
	3.6	Arrangement
    Effective Time	21
	3.7	U.S.
    Federal Securities Law Matters	22
	3.8	U.S.
    State Blue Sky Laws Applicable to Subversive Limited Partners that are U.S. Persons	22
	3.9	Share
    Exchange and Payment under the Arrangement	23
	3.10	U.S.
    Tax Matters.	23
	 	 	 
	ARTICLE
    4 REPRESENTATIONS AND WARRANTIES	24
	 	 	 
	4.1	Representations
    and Warranties of Intercure	24
	4.2	Representations
    and Warranties of Subversive	37
	4.3	Representations
    and Warranties of the General Partner	40
	4.4	Survival	41
	 	 	 
	ARTICLE
    5 COVENANTS	41
	 	 	 
	5.1	Conduct
    of Business by the Parties	41
	5.2	Representations
    and Warranties	41
	5.3	Notice
    of Material Change	42
	5.4	Non-Solicitation	42
	5.5	Mutual
    Negative Covenants	43
	5.6	Intercure
    Negative Covenants	44
	5.7	Support
    of Business Combination	46
	5.8	Other
    Filings	46
	5.9	Additional
    Agreements	46
	5.10	Waiver
    of Access to Escrow Account	47
	5.11	Access	47

 

    	-i-

     

    

 

TABLE
OF CONTENTS 

(continued)

 

	 	Page
	 	 
	ARTICLE
    6 CONDITIONS AND CLOSING MATTERS	48
	 	 	 
	6.1	Mutual
    Conditions Precedent	48
	6.2	Additional
    Conditions Precedent to the Obligations of Intercure	49
	6.3	Additional
    Conditions Precedent to the Obligations of Subversive	50
	6.4	Closing
    Matters	51
	 	 	 
	ARTICLE
    7 TERMINATION AND AMENDMENT	52
	 	 	 
	7.1	Termination	52
	7.2	Effect
    of Termination	52
	7.3	Expenses	52
	7.4	Amendment	52
	7.5	Waiver	52
	 	 	 
	ARTICLE
    8 GENERAL	53
	 	 	 
	8.1	Notices	53
	8.2	Assignment	54
	8.3	Complete
    Agreement	54
	8.4	Further
    Assurances	54
	8.5	Severability	54
	8.6	Counterpart
    Execution	54
	8.7	Investigation
    by Parties	54
	8.8	Public
    Announcement; Disclosure and Confidentiality	54
	8.9	Representative.	55
	 	 	 
	Schedule
    A PLAN OF ARRANGEMENT	A-1

 

    	-ii-

     

    

 

ARRANGEMENT
AGREEMENT

 

THIS
AGREEMENT is made as of February 9, 2021,

 

BY
AND BETWEEN:

 

INTERCURE
LTD.,

a
company incorporated under the laws of the State of Israel, privately held limited liability company number 512051699

(“Intercure”)

 

-and-

 

CANNDOC
ACQUISITION SUBCO LTD.,

a
corporation incorporated under the laws of the Province of British Columbia

(“INTERCURE
BC SUB”)

 

-and-

 

Subversive
Real Estate Acquisition REIT LP,

a
limited partnership established under the laws of the Province of Ontario

(“Subversive”)

 

-and-

 

SUBVERSIVE
REAL ESTATE ACQUISITION REIT (GP) INC.,

a
corporation incorporated under the laws of the Province of British Columbia

(“General
Partner”)

 

-and-

 

SUBVERSIVE
REAL ESTATE SPONSOR LLC,

a
limited liability company organized under the laws of the State of Delaware

(“Representative”)

 

WHEREAS,
Subversive and Intercure are parties to a Definitive Agreement dated January 3, 2021 (the “Prior Agreement”);

 

WHEREAS,
Subversive and Intercure desire to amend and restate the Prior Agreement in its entirety and accept the rights and covenants herein
in lieu of their rights and covenants under the Prior Agreement;

 

WHEREAS,
on the Effective Date, by way of a statutory plan of arrangement under the provisions of the Business Corporations Act (British
Columbia), (i) Intercure BC Sub shall acquire all of the Subversive Limited Partnership Units, and (ii) Intercure BC Sub shall acquire
all of the shares of the General Partner.

 

WHEREAS,
in connection with the consummation of the Arrangement the Parties intend to list the Intercure Shares on Nasdaq and the TSX, and
the Intercure Shares will continue to be listed on TASE;

 

    	-1-

     

    

 

WHEREAS,
the board of directors of Intercure has: (i) determined that this Agreement, the Arrangement and the other transactions contemplated
by this Agreement are fair to, and in the best interests of, Intercure and its shareholders; (ii) approved this Agreement, the Arrangement
and the other transactions contemplated hereby; (iii) determined to recommend that the shareholders of Intercure approve this Agreement,
the Arrangement and the other transactions contemplated hereby; and (iv) confirmed, in accordance with section 282 of the Companies Law,
that subject to the requisite shareholder approval at the shareholders’ meeting, all approvals required for the Arrangement and
the other transactions contemplated hereby have been obtained;

 

WHEREAS,
on its behalf and on Subversive’s, the board of directors of the General Partner of Subversive has: (i) determined that this
Agreement, the Arrangement and the other transactions contemplated by this Agreement are fair to, and in the best interests of, the General
Partner and its shareholder, and Subversive and the Subversive Limited Partners and that, considering the financial position of the Intercure
and Subversive, no reasonable concern exists that Intercure will be unable to fulfill the obligations of either of the General Partner
or Subversive to its creditors; (ii) approved this Agreement, the Arrangement and the other transactions contemplated hereby; and (iii)
determined to recommend that the Subversive Limited Partners approve this Agreement, the Arrangement and the other transactions contemplated
hereby;

 

WHEREAS,
the Arrangement is intended to constitute the “qualifying transaction” (as such term is defined in the Exchange
Listing Manual, the “Qualifying Transaction”) of Subversive; and

 

WHEREAS,
certain Intercure Shareholders have concurrently with the execution and delivery of this Agreement entered into a Support and Lock-Up
Agreement with Subversive.

 

NOW
THEREFORE in consideration of the mutual covenants and agreements herein contained and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged by each of the Parties, the Parties covenant and agree as follows:

 

ARTICLE
1

INTERPRETATION

 

1.1
Definitions

 

In
this Agreement, unless there is something in the subject matter or context inconsistent therewith, the following terms shall have the
following meanings, respectively:

 

“Affiliate”
means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by or is under common control
with such Person. As used herein, the term “control” means (a) the power to vote at least 10% of the voting power of a Person,
or (b) the possession, directly or indirectly, of any other power to direct or cause the direction of the management and policies of
such a Person, whether through ownership of voting securities, by contract or otherwise, or (c) as defined in the Israeli Securities
Law;

 

“Agreement”,
“this Agreement”, “herein”, “hereto”, and “hereof” and similar
expressions refer to this arrangement agreement, including the schedules and exhibits attached hereto, as the same may be amended or
supplemented from time to time;

 

    	-2-

     

    

 

“Arrangement”
means the Arrangement pursuant to section 288 of the BCBCA set forth in the Plan of Arrangement as supplemented, modified or amended,
and not any particular article, section or other portion thereof;

 

“Arrangement
Dissent Rights” means the rights of dissent in respect of the Arrangement described in the Plan of Arrangement;

 

“Balance
Sheet” has the meaning ascribed thereto in Section Error! Reference source not found. hereof;

 

“BCBCA”
means the Business Corporations Act (British Columbia), S.B.C. 2002 c. 57, as amended;

 

“Business
Combination” means the Arrangement and the other transactions contemplated by this Agreement, as detailed in this Agreement,
through which the businesses of Intercure and Subversive will be combined, including the Financing, the Arrangement, the Nasdaq Listing,
the TSX Listing, the TASE listing and the Director Appointments;

 

“Business
Day” means any day, excluding Saturday or Sunday, on which banking institutions are open for business in Toronto, Ontario,
Canada, Tel Aviv, Israel, and New York, New York, United States of America;

 

“Cannabis”
means all parts of the plant Cannabis sativa L. containing more than 0.3 percent THC, whether growing or not; the seeds thereof; the
resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant,
its seeds or resin. The term does not include the mature stalks of such plant, fiber produced from such stalks, oil or cake made from
the seeds of such plant, any other compound, manufacture, salt, derivative, mixture, or preparation of such mature stalks (except the
resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination;

 

“Cannabis
License” means any temporary, provisional, term limited, or permanent permit, license, registration, variance, clearance, consent,
permit, commission, franchise, exemption, order, authorization, or approval from any Governmental Authority that regulates the cultivation,
manufacture, processing, marketing, sale or distribution of Cannabis products, whether for medical or recreational use;

 

“Claim”
has the meaning ascribed thereto in Section 5.10 hereof;

 

“commercially
reasonable efforts” has the meaning ascribed thereto in Section 5.9 hereof;

 

“Companies
Law” means the Israeli Companies Law, together with the rules and regulations promulgated thereunder;

 

“Completion
Deadline” means the latest of (a) April 8, 2021, (b) the outside date for completion of the Qualifying Transaction, if extended
by Subversive beyond April 8, 2021, in accordance with applicable Laws, which shall not be later than September 30, 2021 without the
prior written consent of Intercure, and (c) such later date as may be mutually agreed between the Parties in writing;

 

“Confidential
Information” has the meaning ascribed thereto in Section 8.8(b) hereof;

 

    	-3-

     

    

 

“Court”
means the Supreme Court of British Columbia, sitting in Vancouver, British Columbia, or other court as applicable;

 

“Debt
Instrument” has the meaning ascribed thereto in Section 4.1(w) hereof;

 

“Depositary”
means such Person as Subversive may appoint to act as depositary in relation to the Arrangement;

 

“Designated
Intercure Convertible Securities” means a total of 13,388,800 Intercure Convertible Securities consisting of (i) 3,818,800
Intercure Convertible Securities designated as vested ESOP-A, (ii) 8,570,000 Intercure Convertible Securities designated as Options-A1,
and (iii) 1,000,000 Intercure Convertible Securities designated as Options-A2;

 

“Director
Appointments” means, subject to the completion of the Arrangement, the appointment to the board of directors of Intercure of
additional directors who are currently not directors of Intercure, as more particularly set out in Section 2.3;

 

“Documents”
means this Agreement, the Arrangement Certificate, the Prospectus, the Information Circular, the U.S. Registration Statement, the U.S.
Resale Registration Statement, the Support and Lock-Up Agreements, the Management Lock-Up Agreements, the Indemnification Agreement,
and the Sponsor Lock-Up and Forfeiture Agreement;

 

“DRS
Statement” means a statement evidencing a shareholding position under the Direct Registration System;

 

“Due
Diligence Sessions” means one or more due diligence sessions to be held by the agents appointed by Subversive to act as the
sole and exclusive agents of Subversive to effecting the Financing, and pursuant to which Intercure’s directors, senior management
and auditors were made available to answer questions which such agents may have;

 

“Effective
Date” means the date on which the Arrangement becomes effective;

 

“Effective
Time” means 10 a.m. (Vancouver time) on the Effective Date, or such other time as Intercure and Subversive determine;

 

“Environmental
Laws” has the meaning ascribed thereto in Section 4.1(s) hereof;

 

“Escrow
Account” means the escrow account of Subversive established and maintained by the Escrow Agent, which holds in escrow the gross
proceeds of the initial public offering of the Subversive Class A Restricted Voting Units, including the gross proceeds of the over-allotment
option;

 

“Escrow
Agent” means Olympia Trust Company, in its capacity as escrow agent, under the Escrow Agreement, and its successors and permitted
assigns;

 

“Escrow
Agreement” means the escrow agreement dated January 8, 2020, among Subversive, the Escrow Agent, Canaccord Genuity Corp. and
Echelon Wealth Partners Inc.;

 

“Exchange
Listing Manual” means the Neo Exchange Inc. Listing Manual;

 

“Filed
Documents” has the meaning ascribed thereto in Section 4.1(kk) hereof;

 

    	-4-

     

    

 

“Final
IPO Prospectus” means the final long-form prospectus of Subversive dated December 23, 2019 in connection with its initial public
offering of Subversive Class A Restricted Voting Units;

 

“Final
Order” means the final order of the Court pursuant to Section 291 of the BCBCA approving the Arrangement;

 

“Financing”
means the private placement of Subversive Limited Partnership Units to the PIPE Investors by Subversive on the Effective Date pursuant
to the Subscription Agreements;

 

“Fully
Diluted Intercure Shares” means an aggregate of 133,477,700 Intercure Shares (comprising the number of Intercure Shares issued
or deemed to be issued, as applicable, and outstanding as of the date of this Agreement assuming the exercise or conversion, as applicable,
of all outstanding Designated Intercure Convertible Securities);

 

“Fundamental
Representations” means the Intercure Fundamental Representations and the Subversive Fundamental Representations;

 

“General
Partner” has the meaning ascribed thereto in the preamble of this Agreement;

 

“General
Partner Common Shares” means the one hundred (100) common shares issued and outstanding in the capital of the General Partner;

 

“Going
Public Transaction” means (i) the initial public offering of any class of securities of Intercure or a direct listing application
of Intercure whereby any class of securities of Intercure becomes listed or quoted on a recognized Canadian or United States stock exchange,
or (ii) a reverse takeover, amalgamation, merger, statutory arrangement, share exchange or similar transaction involving Intercure and
a reporting issuer in a province of Canada or state of the United States and which results in the securities of the resulting issuer
from such transaction becoming listed or quoted on a recognized Canadian or United States stock exchange;

 

“Governing
Documents” means, in respect of each Party, as applicable, its certificate, its notice of articles and articles as amended,
its memorandums and/or articles of incorporation/association, as amended, its by-laws, as amended, or its limited partnership agreement,
as amended;

 

“Government
Authority” means any applicable foreign, national, provincial, local or state government, any political subdivision or any
governmental, judicial, public or statutory instrumentality, court, tribunal, agency (including those pertaining to health, safety or
the environment), authority, body or entity, or other regulatory bureau, authority, body or entity having legal jurisdiction over the
activity or Person in question and, for greater certainty, includes the NEO, TSX, OSC, TASE, ISA, the SEC and Nasdaq;

 

“IFRS”
means International Financial Reporting Standards as issued by the International Accounting Standards Board applicable as at the relevant
date;

 

“IMCA”
means the Israeli Medical Cannabis Agency;

 

“Improvements”
has the meaning ascribed thereto in Section 4.1(hh)(ii) hereof;

 

“Indemnification
Agreement” means the indemnification agreement pursuant to which Intercure indemnifies Subversive and its Subsidiaries, Affiliates,
directors, officers and advisers as set forth therein;

 

    	-5-

     

    

 

“Information
Circular” means the notice of the Subversive Meeting to be sent to the Subversive Limited Partners, and the accompanying management
information circular to be prepared in connection with the Subversive Meeting, together with any amendments or supplements thereof in
accordance with the terms of this Agreement;

 

“Intercure”
has the meaning ascribed thereto in the preamble of this Agreement;

 

“Intercure
Agent Warrants” means the options of Intercure issued to dealers and agents in connection with any prior financings of Intercure
of which, as of the date of this Agreement, there are no (0) Intercure Agent Warrants issued and outstanding;

 

“Intercure
BC Sub” has the meaning ascribed thereto in the preamble of this Agreement;

 

“Intercure
Convertible Securities” means, collectively, the Intercure Options, the Intercure Warrants and the Intercure Agent Warrants;

 

“Intercure
Data” means all sensitive data contained in the systems, databases, files or other records of Intercure or any Intercure Subsidiary
and all other information and data compilations used by Intercure or any Intercure Subsidiary, whether or not in electronic form, including
Personal Data;

 

“Intercure
Disclosure Schedules” has the meaning given to such term in Section 4.1;

 

“Intercure
Financial Statements” means, (a) the audited consolidated statement of comprehensive income, a statement of changes in equity
and a statement of cash flows for financial years ended December 31, 2019, 2018 and 2017, together with the notes thereto and the auditors’
report thereon, (b) the unaudited (but reviewed) consolidated statement of financial position as at the end of September 30, 2020 and
2019, together with the notes thereto and (c) such other financial statements of Intercure and any business acquired by Intercure since
December 31, 2016, as are required to be included in the Prospectus and/or the U.S. Registration Statement and/or the U.S. Resale Registration
Statement pursuant to applicable Laws and all prepared in accordance with IFRS;

 

“Intercure
Fundamental Representations” means Sections 4.1(a), (b), (c), (d), (e), (h), (i),
(p) and (jj);

 

“Intercure
Meeting” means a special meeting of the shareholders of Intercure to be held in order to seek shareholder approval for (a)
this Agreement and the Arrangement and the other transactions contemplated herein (including the issuance of Intercure Shares in accordance
with the terms of the Arrangement), (b) to consolidate the registered and issued share capital of Intercure by a ratio of 4.4492567:1
so that each 4.4492567 Intercure Shares shall be consolidated into one (1) new Intercure Share (the “Intercure Share Consolidation”),
(c) assuming the Intercure Share Consolidation, to increase the registered share capital of Intercure by 55,048,671 additional ordinary
shares (from 44,951,329 currently existing after the Intercure Share Consolidation to 100,000,000), (d) to approve the listing of the
Intercure Shares on Nasdaq and TSX, as applicable, (e) to amend the Intercure Governing Documents to reflect the resolutions detailed
herein and any additional amendments required to effect the transactions contemplated by this Agreement, (f) to appoint, subject to completion
of the Arrangment, those new directors to the board of directors of Intercure as detailed in Section 2.3; (g) to amend the current
complensation policy of Intercure to reflect certain directors and officers insurance thresholds required as a result of the transactions
contemplated by this Agreement; and (h) any additional resolutions which may be required for the purpose of completing the Arrangement
and the transactions contemplated thereby;

 

    	-6-

     

    

 

“Intercure
Options” means the stock options to purchase Intercure Shares granted to Intercure’s directors, officers, employees,
contractors and other eligible persons, of which, as of the date of this Agreement, there are 5,338,184 Intercure Options (prior to the
Intercure Share Consolidation) issued and outstanding and 4,303,356 (prior to the Intercure Share Consolidation) that will be issued
by the consummation of the Plan of Arrangement;

 

“Intercure
Share Consolidation” has the meaning ascribed thereto in the definition of Intercure Meeting;

 

“Intercure
Shareholder” means a registered holder of Intercure Shares, from time to time, and “Intercure Shareholders”
means all such holders;

 

“Intercure
Share Value” means the quotient of (i) $300,000,000 divided by (ii) the Fully Diluted Intercure Shares (which results in $2.247566455
prior to the Intercure Share Consolidation and $10.00 after the Intercure Share Consolidation);

 

“Intercure
Shares” means the ordinary shares in the capital of Intercure;

 

“Intercure
Subsidiaries” means the Intercure BC Sub, Canndoc Ltd., Canndoc CBD Ltd., and CannOlam Ltd.;

 

“Intercure
Warrants” means the common share purchase warrants of Intercure of which, as of the date of this Agreement, there are 17,683,788
Intercure Warrants issued and outstanding (prior to the Intercure Share Consolidation);

 

“Interim
Order” means the interim order of the Court contemplated by Section 3.2 of this Agreement and made pursuant to Section
291 of the BCBCA, providing for, among other things, the calling and holding of the Subversive Meeting, as the same may be amended by
the Court, with the consent of Subversive;

 

“in
writing” means written information including documents, files, software, records and books made available, delivered or produced
to one Party by or on behalf of the other Party;

 

“ISA”
means the Israel Securities Authorities;

 

“Israeli
Registrar of Companies” means the Government Authority in the State of Israel responsible for the supervision, registration
and enforcement over corporations in Israel;

 

“Israeli
Securities Law” mean the Israeli Securities Law 1968;

 

“ITA”
means the Israeli Tax Authority;

 

“Laws”
means all laws, statutes, codes, ordinances, decrees, rules, regulations, by laws, statutory rules, principles of law, published policies
and guidelines, judicial or arbitral or administrative or ministerial or departmental or regulatory judgments, orders, decisions, rulings
or awards, including general principles of common and civil law, and terms and conditions of any grant of approval, permission, authority
or license of any Government Authority, statutory body or self-regulatory authority, and the term “applicable” with respect
to such Laws and in the context that refers to one or more Persons, means that such Laws apply to such Person or Persons or its or their
business, undertaking, property or securities and emanate from a Government Authority (or any other Person) having jurisdiction over
the aforesaid Person or Persons or its or their business, undertaking, property or securities;

 

    	-7-

     

    

 

“Leased
Real Property” has the meaning ascribed thereto in Section 4.1(hh)(i) hereof;

 

“Letter
of Transmittal” means a letter of transmittal to be sent to the Subversive Limited Partners for use in connection with the
Arrangement and in order to deliver to the Subversive Limited Partners the Intercure Shares to which they are entitled after giving effect
to the Arrangement;

 

“Management
Lock-Up Agreement” means the voting support and lock-up agreements dated as of the date hereof between Subversive, Intercure
and each Person that is a director of officer of Intercure set forth in Section 1.1 of the Intercure Disclosure Schedules;

 

“Material
Adverse Effect” means any event, change or effect that is or could reasonably be expected to be materially adverse to the financial
condition, operations, assets, liabilities, or business of a Party and its Subsidiaries, considered as a whole, provided, however, that
a Material Adverse Effect shall not include an adverse effect resulting from general economic, financial, currency exchange, securities
or commodity market conditions in Canada, the United States or Israel;

 

“Material
Contract” has the meaning ascribed thereto in Section 4.1(r)(i) hereto;

 

“material
fact” has the meaning ascribed thereto in the Securities Act (Ontario) as the same has been and may hereafter from time
to time be modified, and/or (as applicable) the meaning ascribed to “Misleading item” in the Israeli Securities Law, which
includes something that is likely to mislead a reasonable investor, and any matter the omission of which is likely to mislead a reasonable
investor;

 

“Minimum
Cash Amount” has the meaning ascribed thereto in Section 6.2(d) hereof;

 

“Nasdaq”
means The Nasdaq Stock Market LLC;

 

“Nasdaq
Listing” means the listing of Intercure Shares on Nasdaq;

 

“NEO”
means the Neo Exchange Inc.;

 

“OSC”
means the Ontario Securities Commission;

 

“Party”
means each of Intercure, Intercure BC Sub, Subversive, General Partner and Representative individually, and together, the “Parties”;

 

“Per
Unit Arrangement Consideration” means a number of Intercure Shares equal to the quotient of (i) $10, divided by (ii)
the Intercure Share Value;

 

“Person”
includes any individual, firm, partnership, joint venture, venture capital fund, association, trust, trustee, executor, administrator,
legal personal representative, estate, group, body corporate, corporation, unincorporated association or organization, Government Authority,
syndicate or other entity, whether or not having legal status;

 

    	-8-

     

    

 

“Personal
Data” means all data in the possession, custody or control of Intercure or any Intercure Subsidiary that identifies
or locates a natural person or that, in combination with other reasonably available data, can reasonably be used to identify or locate
a natural person;

 

“PIPE
Investors” means purchasers of Subversive Limited Partnership Units in the Financing pursuant to the Subscription Agreements;

 

“PIPE
Securities” means the Intercure Shares ultimately issued to PIPE Investors in exchange for their Subversive PIPE Securities
in the Arrangement;

 

“Plan”
means the employee share option plan duly adopted by Intercure in March 2015;

 

“Plan
of Arrangement” means the plan of arrangement, substantially in the form appended hereto as Schedule A, and any amendments,
modifications or supplements thereto made in accordance with the terms thereof or made at the direction of the Court in the Final Order;

 

“Prior
Agreement” has the meaning ascribed thereto in the recitals of this Agreement;

 

“Privacy
and Information Security Requirements” means (a) all applicable Laws relating to the Processing of Personal Data, data
privacy or information security, to the extent applicable to Intercure or any Intercure Subsidiary and (b) the Payment Card Industry
Data Security Standards;

 

“Process”
or “Processing” means the collection, use, storage, distribution, transfer, import, export, protection (including
security measures), disposal or disclosure or other activity regarding data (whether electronically or in any other form or medium);

 

“Prospectus”
means the preliminary long form non-offering prospectus and/or final long form non-offering prospectus of Subversive, and any amendment
thereto, as the context requires, containing disclosure regarding, among other things, Subversive, Intercure and the Business Combination
(and any related matters), as the Qualifying Transaction of Subversive;

 

“Qualifying
Transaction” has the meaning ascribed thereto in the recitals of this Agreement;

 

“Real
Property Lease” means each contract whereby Intercure or an Intercure Subsidiary, subleases, licenses, or otherwise holds any
rights to use or occupy any interest in real property;

 

“Reference
Date” has the meaning ascribed thereto in Section 4.1(dd) hereof;

 

“Regulatory
Approval” means any approval, consent, waiver, permit, order or exemption from any Government Authority having jurisdiction
or authority over any Party or the Subsidiary of any Party which is required or advisable to be obtained in order to permit the Business
Combination to be effected and “Regulatory Approvals” means all such approvals, consents, waivers, permits, orders
or exemptions;

 

“Related
Party” means one or more of the following: (a) each Intercure Shareholder who alone or together with such Person’s Affiliates,
owns ten percent (10%) or more of the Intercure Shares, each officer, manager or director of Intercure or an Intercure Subsidiary, each
family member of any Intercure Shareholder of the type referenced above or any director, manager or officer of Intercure or an Intercure
Subsidiary, each trust for the benefit of any of the foregoing, and each Affiliate of any of the foregoing (other than Intercure or an
Intercure Subsidiary); (b) a “control” holder, “interested party” and “substanial shareholder” as
those terms are defined in the Companies Law and/or in the Israeli Securities Law; and (c) any person or entity of whom a control holder
has a “personal interest” (as defined in the Companies Law) in, or in any transaction or action of such person or entity;

 

    	-9-

     

    

 

“Related
Party Transaction” means any contract or arrangement or transaction between Intercure or an Intercure Subsidiary, on the one
hand, and any Related Party, on the other hand;

 

“Reporting
Jurisdictions” has the meaning ascribed thereto in Section 4.2(d) hereof;

 

“Rights
Agent” means Olympia Trust Company;

 

“Rights
Agreement” means the rights agency agreement dated January 8, 2020, between Subversive and the Rights Agent;

 

“SEC”
means the United States Securities and Exchange Commission;

 

“Securities
Act” means the United States Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder;

 

“Securities
Exchange Act” means the United States Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder;

 

“Securities
Laws” means the Securities Act (Ontario) and all the securities laws of each province and territory of Canada, except
Quebec, the rules, regulations and policies of the NEO and the TSX, the Securities Act, the Securities Exchange Act, the rules and regulations
of Nasdaq, the Israeli Securities Law and the rules, regulations and policies of the TASE;

 

“SPACs”
means special purpose acquisition corporations;

 

“Sponsor”
means Subversive Real Estate Sponsor LLC, a Delaware limited liability company;

 

“Sponsor
Lock-Up and Forfeiture Agreement” means that certain Sponsor Lock-Up and Forfeiture Agreement, executed by Sponsor and the
other parties thereto;

 

“Subscription
Agreements” means the subcripton agreements pursuant to which, subject to the terms and conditions contained therein, the PIPE
Investors agreed to purchase from Subversive, and Subversive agreed to sell to the PIPE Investors, Subversive Limited Partnership Units
in the Financing, which Subversive Limited Partnership Units shall ultimately be acquired by Intercure BC Sub pursuant to the terms of
the Arrangement;

 

“Subsidiary”
means, (a) with respect to any Person, any corporation, limited liability company, partnership, association or business entity of which
(i) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency)
to vote in the election of directors, managers, or trustees thereof is at the time owned or controlled, directly or indirectly, by that
Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (ii) if a limited liability company, partnership,
association, or other business entity (other than a corporation), a majority of partnership or other similar ownership interest thereof
is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person or a combination
thereof. For purposes hereof, a Person or Persons shall be deemed to have a majority ownership interest in a limited liability company,
partnership, association or other business entity (other than a corporation) if such Person or Persons shall be allocated a majority
of limited liability company, partnership, association, or other business entity gains or losses or shall be or control any manager,
managing director or general partner of such limited liability company, partnership, association or other business entity; and (b) “Subsidiary”
and/or “Affiliated company” and/or “Associated company” as these terms are defined in the Israeli Securities
Law;

 

    	-10-

     

    

 

“Subversive”
has the meaning ascribed thereto in the preamble of this Agreement;

 

“Subversive
Arrangement Resolution” means a special resolution of the Subversive Limited Partners in respect of the Arrangement to be considered
at the Subversive Meeting;

 

“Subversive
Class A Restricted Voting Units” means the class A restricted voting units of Subversive issued pursuant to the Final IPO Prospectus,
each consisting of one Subversive Restricted Voting Unit and one Subversive Right;

 

“Subversive
Class B Units” means the Class B units of Subversive, each comprised of 1/100 of a Subversive Proportionate Voting Unit and
one Subversive Right;

 

“Subversive
Disclosure Schedules” has the meaning ascribed thereto in Section 4.2 hereof;

 

“Subversive
Financial Statements” has the meaning ascribed thereto in Section 4.2(k)(i) hereof;

 

“Subversive
Fundamental Representations” means Sections 4.2(a), (b), (c), (d), (i), (j), and
(o);

 

“Subversive
Limited Partners” means the limited partners of Subversive;

 

“Subversive
Limited Partnership Units” means the Subversive Restricted Voting Units following the renaming of such class of securities
to “Limited Partnership Units” pursuant to the Plan of Arrangement;

 

“Subversive
Meeting” means the meeting of the Subversive Limited Partners, including any adjournment or postponement thereof in accordance
with the terms of this Agreement, that is to be convened as provided by the Interim Order to consider, and if deemed advisable approve,
the Subversive Arrangement Resolution;

 

“Subversive
PIPE Securities” has the meaning ascribed thereto in the definition of “Financing” herein;

 

“Subversive
Proportionate Voting Unit” means the proportionate voting limited partnership units of Subversive;

 

“Subversive
Required Approval” means the approval of not less than two-thirds of the Subversive Limited Partners, voting together as a
single class, present in person or by proxy at the Subversive Meeting;

 

“Subversive
Restricted Voting Unit” means the restricted voting limited partnership units of Subversive;

 

“Subversive
Right” means the rights to receive, for no additional consideration, one-eighth (1/8) of one Restricted Voting Unit following
the Effective Time (which at such time will represent one-eighth (1/8) of a Subversive Limited Partnership Unit, subject to adjustment
under the terms of the Rights Agreement);

 

    	-11-

     

    

 

“Subversive
Securities Authorities” means the applicable securities commissions or similar securities regulatory authorities in each of
the Reporting Jurisdictions;

 

“Subversive
Subsidiaries” means Canndoc Acquisition Finco Ltd. and Canndoc Acquisition Pubco Ltd.;

 

“Support
and Lock-Up Agreement” means the voting support and lock-up agreements dated as of the date hereof between Subversive, Intercure
and each Person set forth on Section 1.1 of the Intercure Disclosure Schedules;

 

“TASE”
means the Tel-Aviv Stock Exchange;

 

“Tax
Ordinance” means the Israeli Income Tax Ordinance [New-Version] – 1961, as amended, and the rules and regulations promulgated
thereunder;

 

“Taxes”
has the meaning ascribed thereto in Section 4.1(o) hereof;

 

“Top
Customer” has the meaning ascribed thereto in Section 4.1(ee) hereof;

 

“Top
Supplier” has the meaning ascribed thereto in Section 4.1(ff) hereof;

 

“TSX”
means the Toronto Stock Exchange;

 

“TSX
Listing” means the listing and posting for trading of the Intercure Shares on the TSX;

 

“U.S.
Registration Statement” has the meaning ascribed thereto in Section 2.2(c);

 

“U.S.
Resale Registration Statement” has the meaning ascribed thereto in Section 2.2(d); and

 

“United
States” means the United States of America, its territories and possessions, any state of the United States, and the District
of Columbia.

 

1.2
Amendment and Restatement

 

The
Prior Agreement is hereby amended in its entirety and restated herein. Such amendment and restatement is effective upon the execution
of this Agreement by each of the Parties hereto. Upon such execution, all provisions of, rights granted and covenants made in the Prior
Agreement are hereby waived, released and superseded by this Agreement in their entirety and shall have no further force or effect.

 

1.3
Singular, Plural, etc.

 

Words
importing the singular number include the plural and vice versa and words importing gender include all genders.

 

1.4
Deemed Currency

 

In
the absence of a specific designation of any currency any undescribed dollar amount herein shall be deemed to refer to United States
dollars.

 

    	-12-

     

    

 

1.5
Headings, etc.

 

The
division of this Agreement into Articles and Sections, the provision of a table of contents hereto and the insertion of the recitals
and headings are for convenience of reference only and shall not affect the construction or interpretation of this Agreement and, unless
otherwise stated, all references in this Agreement to Articles and Sections refer to Articles and Sections of and to this Agreement in
which such reference is made.

 

1.6
Date for any Action

 

In
the event that any date on which any action is required to be taken hereunder by any of the Parties hereunder is not a Business Day,
such action shall be required to be taken on the next succeeding day that is a Business Day.

 

1.7
Governing Law

 

This
Agreement shall be governed by and interpreted in accordance with the Laws of the Province of British Columbia and the Laws of Canada
applicable therein. Notwithstanding the foregoing, the Plan of Arrangement will be governed by the Laws of the Province of British Columbia
and the Laws of Canada applicable therein.

 

1.8
Attornment

 

The
Parties hereby irrevocably and unconditionally consent to and submit to the courts of the Province of British Columbia for any actions,
suits or proceedings arising out of or relating to this Agreement or the matters contemplated hereby (and agree not to commence any action,
suit or proceeding relating thereto except in such courts) and further agree that service of any process, summons, notice or document
by single registered mail to the addresses of the Parties set forth in this Agreement shall be effective service of process for any action,
suit or proceeding brought against either Party in such court. The Parties hereby irrevocably and unconditionally waive any objection
to the laying of venue of any action, suit or proceeding arising out of this Agreement or the matters contemplated hereby in the courts
of the Province of British Columbia and hereby further irrevocably and unconditionally waive and agree not to plead or claim in any such
court that any such action, suit or proceeding so brought has been brought in an inconvenient forum.

 

1.9
Schedules and Exhibits

 

The
Schedules and Exhibits to this Agreement, including the Intercure Disclosure Schedules and the Subversive Disclosure Schedules, are hereby
incorporated and made a part hereof and are an integral part of this Agreement.

 

ARTICLE
2

THE BUSINESS COMBINATION

 

2.1
Business Combination Steps

 

Intercure
and Subversive agree to effect the combination of their respective businesses and assets by way of a series of steps or transactions
including the Financing, the Plan of Arrangement, the Arrangement, the Nasdaq Listing, the TSX Listing, the TASE Listing and the Director
Appointments. Each Party hereby agrees that as soon as reasonably practicable after the date hereof or at such other time as is specifically
indicated below in this Section 2.1, and subject to the terms and conditions of this Agreement, it shall take the following steps
indicated for it:

 

	 	(a)	Intercure
    Meeting. Intercure shall duly call and convene the Intercure Meeting at which the Intercure Shareholders will be asked to approve
    the resolutions proposed for approval at the Intercure Meeting and Intercure shall use all commercially reasonable efforts to obtain
    the approval of the Intercure Shareholders for the foregoing matters.

 

    	-13-

     

    

 

	 	(b)	Intercure
    to Enter Into Registration Rights Agreement with Certain PIPE Investors. As soon as practicable after signing this Agreement,
    Intercure shall enter into a registration rights agreement with certain of the PIPE Investors pursuant to the terms of certain of
    the Subscription Agreements (the “Registration Rights Agreement”).
	 	 	 
	 	(c)	Financing.
    Prior to the Effective Time, the PIPE Investors will invest cash for Subversive Limited Partnership Units.
	 	 	 
	 	(d)	Intercure
    Submission to the IMCA. As promptly as practicable and not later than five (5) Business Days after the execution and delivery
    of this Agreement, Intercure will submit to the IMCA the application for approval of the Director Appointments which require the
    approval of the IMCA and any new shareholder of Intercure, post-Effective Date, whose shareholding in Intercure (after giving effect
    to the Arrangement) exceeds 5% of the Intercure issued and outstanding share capital, in a form approved by Subversive.
	 	 	 
	 	(e)	Plan
    of Arrangement. 

 

	 	(i)	Subversive
    and Intercure agree that the Arrangement will be implemented in accordance with and subject to the terms and conditions contained
    in this Agreement and in the Plan of Arrangement, as set forth in more detail in Article 3.
	 	 	 
	 	(ii)	As
    a result of the Arrangement:

 

	 	(A)	Each
    Subversive Limited Partnership Unit shall be exchanged for a number of Intercure Shares equal to the Per Unit Arrangement Consideration;
    provided that the total number of Intercure Shares issued to any Subversive Limited Partner, if not a round number, shall be rounded
    down to the nearest whole number of Intercure Shares;
	 	 	 
	 	(B)	Subversive
    will become a wholly-owned Subsidiary of Intercure BC Sub and will be dissolved; and
	 	 	 
	 	(C)	Intercure
    will purchase the General Partner Common Shares for a total of US$100.00.

 

	 	(f)	ISA
    Approval. The TASE and ISA, as applicable, shall approve for trading on TASE those Intercure Shares issued hereunder to the Subversive
    Limited Partners, provided that immediately prior to such issuance the Intercure Shares shall be traded on TSX and all requirements
    for obtaining “dual listing” status for the trading of Intercure Shares on both TSX and TASE have been complied with,
    including an opinion of Canadian counsel to Intercure and TASE that under TSX and OSC rules and regulations such shares are freely
    tradable on the TSX and TASE.

 

    	-14-

     

    

 

	 	(g)	Compliance
    with U.S. State Blue Sky Laws. As promptly as practicable, the Parties shall seek to determine in what U.S. jurisdictions, if
    any, persons that are to receive Intercure Shares pursuant to the Arrangement reside (if an individual) or have their principal place
    of business (if an entity) and seek to comply with applicable U.S. state blue sky laws in connection with the issuance of Intercure
    Shares pursuant to the Arrangement.
	 	 	 
	 	(h)	Reconstitution
    of Board. Upon consummation of the Arrangement, Intercure will add additional directors to its board of directors to give effect
    to the Director Appointments.
	 	 	 
	 	(i)	U.S.
    Registration Statement and Resale Registration Statement. Prior to the consummation of the Arrangement, Intercure will register
    the Intercure Shares under Section 12(b) of the Securities Exchange Act on Form 20-F or another appropriate form (such form, the
    “U.S. Registration Statement”). Pursuant to the Registration Rights Agreement, on the the earlier of (i) immediately
    following the filing of the first amendment to the U.S. Registration Statement, and (ii) the tenth (10th) Business Day after the
    date Intercure is notified in writing by the staff of the SEC that the U.S. Registration Statement will not be “reviewed”,
    Intercure shall file a registration statement to register the resale of the PIPE Securities on an appropriate registration statement
    under the Securities Act (the “U.S. Resale Registration Statement”).
	 	 	 
	 	(j)	Nasdaq
    Listing. As soon as practicable after the filing of the U.S. Registration Statement, Intercure shall submit a listing application
    for the Nasdaq Listing (the “Nasdaq Listing Application”). Immediately prior to consummation of the Arrangement,
    Intercure intends to obtain approval for the Nasdaq Listing of the Intercure Shares.
	 	 	 
	 	(k)	TSX
    Listings. Prior to consummation of the Arrangement, (i) Subversive Limited Partnership Units shall be listed on the TSX and (ii)
    Intercure intends to obtain approval for the TSX Listing of the Intercure Shares and commence trading of its shares on TSX.
	 	 	 
	 	(l)	NEO
    Delisting. At the Effective Time, Subversive will delist from the NEO.
	 	 	 
	 	(m)	Other
    Actions, etc. The Parties shall take any other action and do anything, including the execution of any other agreements, documents
    or instruments that are necessary or useful to give effect to the Business Combination.

 

2.2
Implementation Covenants

 

	 	(a)	Preparation
    of Prospectus.

 

	 	(i)	Subversive
    shall, in consultation with Intercure and its advisors, as promptly as reasonably practicable, prepare and file the Prospectus with
    the NEO and the Subversive Securities Authorities, as applicable, in accordance with applicable Securities Laws. Intercure shall,
    and shall cause each of the Intercure Subsidiaries to, provide to Subversive: (x) in writing all necessary information concerning
    Intercure and the Intercure Subsidiaries that is required in order for the Prospectus to provide full, true and plain disclosure
    of all material facts relating Intercure and the Intercure Subsidiaries, to ensure that no material fact or information will have
    been omitted from the Prospectus which is required to be stated therein or is necessary to make the statements or information contained
    therein not misleading in light of the circumstances under which they are made, and to otherwise comply with the requirements of
    applicable Securities Law (including the Intercure Prospectus Financial Statements and related management’s discussion and
    analysis); and (y) such assistance as may be reasonably required in connection with the preparation of the Prospectus.

 

    	-15-

     

    

 

	 	(ii)	Intercure
    shall provide Subversive and its auditor access to and the opportunity to review all financial statements and financial information
    of Intercure that is required in connection with the preparation of the Prospectus (including the Intercure Prospectus Financial
    Statements and related management’s discussion and analysis). Intercure hereby: (x) consents to the inclusion of any such financial
    statements in the Prospectus, and (y) agrees to cause to be provided appropriate signatures where required and to obtain any necessary
    consents from any of its auditors and any other advisors to the use of any financial or other expert information required to be included
    in the Prospectus. In the event the OSC requires a promotor to sign the Prospectus, Intercure shall sign the Prospectus as a promoter;
    provided that Subversive shall use all commercially reasonably efforts in compliance with applicable Laws to avoid Intercure being
    required to sign the Prospectus as promoter. Intercure further agrees to provide such financial information and assistance as may
    be reasonably required in connection with any pre-filing or exemptive relief application in respect of disclosure in the Prospectus
    and in connection with the preparation of any pro-forma financial statements for inclusion in the Prospectus. Intercure will certify
    to Subversive that all information and statements provided by Intercure related to the Intercure Subsidiaries for inclusion in the
    preliminary Prospectus, the final Prospectus and the redemption deadline for the Subversive Restricted Voting Units, will be at the
    date the information and statements are provided, and will be at the proposed date of filing of the preliminary and final Prospectus,
    accurate and contain no misrepresentation and constitute full, true and plain disclosure of all material facts relating to Intercure
    and the Intercure Subsidiaries, as required to be disclosed by Subversive in the Prospectus pursuant to applicable Securities Laws
    and no material fact or information will have been omitted from such disclosure which is required to be stated in such disclosure
    or is necessary to make the statements or information contained in such disclosure not misleading in light of the circumstances under
    which they are made.
	 	 	 
	 	(iii)	The
    Parties shall cooperate with one another in connection with the preparation and filing of the Prospectus and shall use their commercially
    reasonable efforts to obtain the approval of the NEO and a receipt for Subversive’s final Prospectus from the Subversive Securities
    Authorities, including providing or submitting on a timely basis all documentation and information that is reasonably required or
    advisable in connection with obtaining such approvals. Upon the reasonable request of Subversive, Intercure shall cause its directors
    and executive officers who are required or requested by a Governmental Authority to deliver personal information forms under the
    rules of the NEO and/or Securities Laws to complete and deliver such forms in a timely manner.
	 	 	 
	 	(iv)	The
    Parties shall jointly seek to ensure that the Prospectus complies in all material respects with applicable Securities Laws, does
    not contain any misrepresentation (except that Subversive shall not be responsible for any information or financial statements relating
    to Intercure or the Intercure Subsidiaries that was approved for inclusion therein by Intercure, acting reasonably, and except that
    Intercure shall not be responsible for any information or financial statements relating to Subversive that was approved for inclusion
    therein by Subversive, acting reasonably), and is in a form satisfactory to the NEO and to the Subversive Securities Authorities
    in order to obtain a receipt from the Subversive Securities Authorities in respect thereof.
	 	 	 
	 	(v)	Subversive
    shall give Intercure and its auditors and legal counsel a reasonable opportunity to review and comment on drafts of the Prospectus
    and other related documents, and shall give reasonable consideration to any comments made by Intercure and its auditors and legal
    counsel and agrees that all information relating to Intercure included in the Prospectus must be in a form and content satisfactory
    to Intercure, acting reasonably, and shall, subject to obtaining NEO and receipt of Subversive’s final Prospectus from the
    Subversive Securities Authorities, cause the Prospectus to be filed on SEDAR (and sent to each Subversive Shareholder) as required
    by applicable Securities Laws.

 

	 	(b)	Preparation
    of Intercure Meeting Documentation. Intercure shall duly prepare documentation required in connection with the Intercure Meeting,
    and deliver such documentation to all Intercure Shareholders.
	 	 	 
	 	(c)	Preparation
    of U.S. Registration Statement.

 

	 	(i)	As
    promptly as reasonably practicable following the date of this Agreement, Intercure and Subversive shall prepare and mutually agree
    upon (such agreement not to be unreasonably withheld, conditioned or delayed by either Subversive or Intercure, as applicable) and
    file the U.S. Registration Statement of Intercure, all in accordance with and as required by applicable Laws, and any applicable
    rules and regulations of the SEC and Nasdaq.

 

    	-16-

     

    

 

	 	(ii)	Each
    of Intercure and Subversive shall use its commercially reasonable efforts to (i) cause the U.S. Registration Statement to comply
    in all material respects with the applicable rules and regulations promulgated by the SEC (including, with respect to Intercure and
    the Intercure Subsidiaries, the provision of financial statements of, and any other information with respect to, Intercure and the
    Intercure Subsidiaries for all periods, and in the form, required to be included in the U.S. Registration Statement under Securities
    Laws (after giving effect to any waivers received) or in response to any comments from the SEC); (ii) promptly notify the others
    of, reasonably cooperate with each other with respect to and respond promptly to any comments of the SEC or its staff; and (iii)
    have the U.S. Registration Statement declared effective under the Securities Act as promptly as reasonably practicable after it is
    filed with the SEC. Intercure, on the one hand, and Subversive, on the other hand, shall promptly furnish, or cause to be furnished,
    to the other all information concerning such Party, its Affiliates and their respective representatives that may be required or reasonably
    requested in connection with any action contemplated by this Section 2.2(c) or for including in any other statement, filing,
    notice or application made by or on behalf of Intercure or Subversive to the SEC or Nasdaq in connection with the transactions contemplated
    by this Agreement.
	 	 	 
	 	(iii)	If
    any Party becomes aware of any information that should be disclosed in an amendment or supplement to the U.S. Registration Statement,
    then (i) such Party shall promptly inform the other Parties; (ii) such Party shall prepare and mutually agree upon with the other
    Parties (in either case, such agreement not to be unreasonably withheld, conditioned or delayed), an amendment or supplement to the
    U.S. Registration Statement; and (iii) Intercure shall file such mutually agreed upon amendment or supplement with the SEC.
	 	 	 
	 	(iv)	Intercure
    shall as promptly as reasonably practicable advise Subversive of the time of effectiveness of the U.S. Registration Statement. Each
    of the Parties shall use commercially reasonable efforts to ensure that none of the information related to such Party or any of its
    Affiliates or its or their respective representatives, supplied by or on his, her or its behalf for inclusion or incorporation by
    reference in the U.S. Registration Statement will, at the time the U.S. Registration Statement is initially filed with the SEC, at
    each time at which it is amended, or at the time it becomes effective under the Securities Act contain any untrue statement of a
    material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light
    of the circumstances under which they are made, not misleading.

 

	 	(d)	Preparation
    of U.S. Resale Registration Statement. Intercure shall prepare the U.S. Resale Registration Statement.
	 	 	 
	 	(e)	ISA
    and TASE Approval. Intercure shall use all commercially reasonable efforts to obtain ISA’s and TASE’s approval to
    the “dual listing” status of Intercure, subject to the TSX Listing, and the free tradeability of Intercure Shares listed
    on the TSX.
	 	 	 
	 	(f)	Nasdaq
    and TSX Listings. Subversive and Intercure shall use all commercially reasonable efforts to cause the Nasdaq Listing, the Subversive
    listing on the TSX and TSX Listing to occur immediately prior to the consummation of the Arrangement.
	 	 	 
	 	(g)	NEO
    Delisting. Subversive and Intercure shall use all commercially reasonable efforts to cause the delisting of Subversive Restricted
    Voting Units to occur.

 

    	-17-

     

    

 

	 	(h)	Preparation
    of Filings and Meeting Documentation. Intercure and Subversive shall cooperate in the preparation of any documents and taking
    of all actions reasonably deemed by Intercure or Subversive to be necessary to discharge their respective obligations under applicable
    Laws in connection with the Business Combination and all other matters contemplated in the Documents, and in connection therewith:

 

	 	(i)	each
    of Intercure and Subversive shall furnish to the other all such information concerning it, its Subsidiaries and Affiliates and its
    shareholders or limited partners as may be required to effect the actions described in this Article 2, and each covenants
    that no information furnished by it in connection with such actions or otherwise in connection with the consummation of the Business
    Combination will contain any untrue statement of a material fact or omit to state a material fact required to be stated in any such
    document or necessary in order to make any information so furnished for use in any such document not misleading in the light of the
    circumstances in which it is furnished or to be used; and
	 	 	 
	 	(ii)	Intercure
    and Subversive shall each promptly notify the other if at any time before the Effective Date it becomes aware that the Information
    Circular, the Prospectus, the U.S. Registration Statement or the U.S. Resale Registration Statement contains any untrue statement
    of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements contained
    therein not misleading in light of the circumstances in which they are made, or that otherwise requires an amendment or supplement
    to the Information Circular, the Prospectus, the U.S. Registration Statement or the U.S. Resale Registration Statement. In any such
    event, Intercure and Subversive shall cooperate in the preparation of a supplement or amendment to the Information Circular, Prospectus,
    the U.S. Registration Statement or the U.S. Resale Registration Statement, as applicable, as required and as the case may be, and,
    if required, shall cause the same to be filed with the Subversive Securities Authorities or the SEC, as applicable.

 

2.3
Board of Directors and Senior Officers

 

Each
of the Parties hereby agrees that upon completion of the Business Combination and giving effect to the Director Appointments, and subject
to compliance with applicable Securities Laws and the rules of the Nasdaq and the TSX, the board of directors and senior officers of
Intercure shall consist of the following:

 

	Name	 	Title
	Ehud
    Barak	 	Director
    and Chairman of the Board
	Alex
    Rabinovitch	 	Director
    and Chief Executive Officer
	David
    Salton	 	Director
	Lennie
    Grinbaum	 	External
    Director
	Gideon
    Hirshfeld	 	External
    Director
	Alon
    Granot	 	Director
	Michael
    Auerbach	 	Director
    (new director to be appointed subject to completion of the Arrangement)
	Amos
    Cohen	 	Chief
    Financial Officer
	Rami
    Levi	 	Chief
    Operating Officer

 

    	-18-

     

    

 

ARTICLE
3

ARRANGEMENT

 

3.1
The Arrangement

 

On
the terms and subject to the conditions of this Agreement, the Parties shall proceed to effect the Arrangement under Part 9, Division
5 of the BCBCA at the Effective Time, on the terms contained in the Plan of Arrangement.

 

3.2
The Interim Order

 

As
soon as reasonably practicable after the date of this Agreement, the General Partner and Subversive shall apply pursuant to Part 9, Division
5 of the BCBCA and, in cooperation with Intercure, prepare, file and diligently pursue an application to the Court for the Interim Order
in respect of the Arrangement, which shall provide, among other things:

 

	 	(a)	For
    the class of persons to whom notice is to be provided in respect of the Arrangement and the Subversive Meeting and for the manner
    in which such notice is to be provided;
	 	 	 
	 	(b)	That
    the required level of approval for the Subversive Arrangement Resolution shall be the Subversive Required Approval;
	 	 	 
	 	(c)	That,
    in all other respects, the terms, restrictions and conditions of the Subversive Governing Documents, including quorum requirements
    and all other matters, shall apply in respect of the Subversive Meeting;
	 	 	 
	 	(d)	For
    the grant of the Arrangement Dissent Rights to those Subversive Limited Partners who are registered Subversive Limited Partners;
	 	 	 
	 	(e)	For
    the notice requirements with respect to the presentation of the application to the Court for the Final Order;
	 	 	 
	 	(f)	That
    the Subversive Meeting may be adjourned or postponed from time to time by Subversive, in accordance with the terms of this Agreement
    and without the need for additional approval of the Court;
	 	 	 
	 	(g)	That
    the record date for the Subversive Limited Partners entitled to notice of and to vote at the Subversive Meeting will not change in
    respect of any adjournment(s) or postponement(s) of the Subversive Meeting;
	 	 	 
	 	(h)	That
    it is Intercure’s intention to rely upon the exemption from registration provided by Section 3(a)(10) of the Securities Act
    with respect to the issuance of Intercure Shares pursuant to the Arrangement, based on the Court’s approval of the Arrangement;
    and
	 	 	 
	 	(i)	For
    such other matters as the Parties may agree are reasonably necessary to complete the Business Combination.

 

    	-19-

     

    

 

3.3
The Company Meeting; Information Circular

 

	 	(a)	Subject
    to the terms of this Agreement and the Interim Order, Subversive shall convene and conduct the Subversive Meeting in accordance with
    Subversive’s Governing Documents, applicable Laws and the Interim Order as soon as reasonably practicable. Subversive shall
    use its commercially reasonable efforts to obtain the Subversive Required Approval of the Subversive Arrangement Resolution, including
    instructing the management proxyholders named in the Information Circular to vote any discretionary or blank proxy submitted by shareholders
    in favor of such action, and shall take all other action reasonably necessary or advisable to secure the Subversive Required Approvals;
	 	 	 
	 	(b)	Subversive
    shall promptly prepare and complete the Information Circular together with any other documents required by applicable Law in connection
    with the Subversive Meeting and the Arrangement, and Subversive shall, as promptly as practicable after obtaining the Interim Order,
    cause the Information Circular and such other documents to be sent to each Subversive Limited Partner and other person as required
    by the Interim Order and Law.
	 	 	 
	 	(c)	Subversive
    shall ensure that the Information Circular (i) complies with the Subversive Governing Documents and applicable Law, (ii) does not
    contain any misrepresentation, except with respect to the Intercure information included in the Information Circular, which Intercure
    will ensure does not contain a misrepresentation, (iii) provides the Subversive Limited Partners with sufficient information (explained
    in sufficient detail) to permit them to form a reasoned judgement concerning the matters to be placed before the Subversive Meeting
    and (iv) states any material interest of each director and officer, whether as director, officer, securityholder or creditor of the
    Company, as and to the extent required by applicable Law.
	 	 	 
	 	(d)	Subversive
    shall, subject to the terms of this Agreement, ensure that the Information Circular includes a statement that the board of directors
    of the General Partner has (i) determined that the Business Combination is in the best interests of Subversive and fair to the Subversive
    Limited Partners and (ii) recommended that the Subversive Limited Partners vote in favor of the Subversive Arrangement Resolution.
	 	 	 
	 	(e)	Intercure
    shall assist Subversive in the preparation of the Information Circular, including obtaining and furnishing to Subversive any information
    with respect to Intercure required to be included under applicable Laws in the Information Circular, and ensuring that such information
    does not contain any misrepresentation.

 

    	-20-

     

    

 

	 	(f)	Each
    party shall promptly notify the other party if it becomes aware that the Information Circular contains a misrepresentation, or otherwise
    requires an amendment or supplement. The parties shall co-operate in the preparation of any such amendment or supplement as required
    or appropriate, and Subversive shall promptly deliver or otherwise disseminate any such amendment or supplement to the Subversive
    Limited Partners as required by the Court or applicable Law.

 

3.4
The Final Order

 

The
General Partner and Subversive shall take all steps necessary or desirable to submit the Arrangement to the Court and diligently pursue
an application for the Final Order pursuant to Part 9, Division 5 of the BCBCA, as soon as reasonably practicable, but in any event not
later than three (3) Business Days after the Subversive Arrangement Resolution is passed at the Subversive Meeting as provided for in
the Interim Order.

 

3.5
Court Proceedings

 

	 	(a)	In
    connection with all Court proceedings relating to obtaining the Interim Order and the Final Order, the General Partner and Subversive
    shall:

 

	 	(i)	Diligently
    pursue, and cooperate with Intercure in diligently pursuing, the Interim Order and the Final Order;
	 	 	 
	 	(ii)	Ensure
    that all material filed with the Court in connection with the Arrangement is consistent with this Agreement and the Plan of Arrangement;
    and
	 	 	 
	 	(iii)	subject
    to this Agreement, oppose any proposal from any person that the Final Order contain any provision inconsistent with the Arrangement
    or this Agreement.

 

	 	(b)	Subject
    to the terms of this Agreement, Intercure will cooperate with, and assist the General Partner and Subversive in, seeking the Interim
    Order and the Final Order, including by providing the General Partner and Subversive on a timely basis any information reasonably
    required or requested to be supplied by Intercure in connection therewith.

 

3.6
Arrangement Effective Time

 

As
promptly as practicable after the satisfaction or, if permissible, waiver of the conditions set forth in Article 6 (other than those
conditions that by their nature are to be satisfied at the Closing, it being understood that the occurrence of the completion of the
Arrangement shall remain subject to the satisfaction or, if permissible, waiver of such conditions at the completion), or at such other
time as the General Partner, Subversive and Intercure may agree in writing, the parties hereto shall cause consummation of the Arrangement
to become effective at the Effective Time in accordance with the Plan of Arrangement.

 

    	-21-

     

    

 

3.7
U.S. Federal Securities Law Matters

 

The
Parties agree that the Arrangement will be carried out with the intention that all Intercure Shares issued pursuant to the Arrangement
to the Subversive Limited Partners will be issued by Intercure in reliance on the exemption from the registration requirements of the
Securities Act provided by Section 3(a)(10) thereunder. In order to ensure the availability of the exemption under Section 3(a)(10) of
the Securities Act, the Parties agree that the Arrangement will be carried out on the following basis:

 

	 	(a)	The
    procedural and substantive fairness of the terms and conditions of the Arrangement will be subject to the approval of the Court;
	 	 	 
	 	(b)	The
    Court will be advised as to the intention of the Parties to rely on the exemption provided by Section 3(a)(10) of the Securities
    Act prior to the hearing required to approve the procedural and substantive fairness of the terms and conditions of the Arrangement;
	 	 	 
	 	(c)	The
    Court will be required to satisfy itself as to the procedural and substantive fairness of the terms and condition of the Arrangement
    to the Subversive Limited Partners, subject to the Arrangement;
	 	 	 
	 	(d)	Subversive
    will ensure that each Subversive Limited Partners entitled to receive Intercure Shares on completion of the Arrangement will be given
    adequate notice advising them of their right to attend the hearing of the Court to approve the procedural and substantive fairness
    of the terms and conditions of the Arrangement and providing them with sufficient information necessary for them to exercise that
    right; 
	 	 	 
	 	(e)	The
    Subversive Limited Partners entitled to receive Intercure Shares will be advised that the Intercure Shares issued pursuant to the
    Arrangement have not been registered under the Securities Act and will be issued by Intercure in reliance on the exemption provided
    by Section 3(a)(10) of the Securities Act;
	 	 	 
	 	(f)	The
    Final Order approving the terms and conditions of the Arrangement that is obtained from the Court will expressly state that the Arrangement
    is approved by the Court as being procedurally and substantively fair to the Subversive Limited Partners;
	 	 	 
	 	(g)	The
    Interim Order approving the Subversive Meeting will specify that each Subversive Limited Partners will have the right to appear before
    the Court at the hearing of the Court to give approval of the Arrangement so long as they enter an appearance within a reasonable
    time; and
	 	 	 
	 	(h)	The
    Court will hold a hearing before approving the procedural and substantive fairness of the terms and conditions of the Arrangement.

 

3.8
U.S. State Blue Sky Laws Applicable to Subversive Limited Partners that are U.S. Persons

 

The
Parties understand and acknowledge that the Intercure Shares issued pursuant to Section 3(a)(10) of the Securities Act will not be “covered
securities” under Section 18(b) of the Securities Act and, to the extent such Intercure Shares are issued to U.S. Persons (as such
term is defined under Regulation S promulgated under the Securities Act), they are not exempt from the registration or qualification
requirements of U.S. state blue sky laws.

 

    	-22-

     

    

 

3.9
Share Exchange and Payment under the Arrangement

 

	 	(a)	Upon
    the issuance of the Certificate of Arrangement: (i) Intercure shall issue a number of Intercure Shares to satisfy the consideration
    issuable to the Subversive Limited Partners hereunder and under the Plan of Arrangement; (ii) Intercure shall deposit share certificates
    together with TASE approval and ancillary documentation with a registration company to be agreed; (iii) the registration company
    credits the Subversive Limited Partners as the recipients of the Intercure Shares; and (iv) certificates formerly representing Subversive
    Limited Partnership Units which are held by such Subversive Limited Partners shall cease to represent any claim upon or interest
    in Subversive other than the right of the registered holder to receive the number of Intercure Shares to which it is entitled hereunder,
    all in accordance with the provisions of the Arrangement.
	 	 	 
	 	(b)	As
    soon as reasonably practicable after the Effective Date, a bank, custodian, depositary or other appropriate agent to be agreed by
    the Parties will forward to, or hold for pick-up by, each former Subversive Limited Partner that submitted a duly completed Letter
    of Transmittal, or similar statement or other evidence of entitlement to such depositary or agent, together with the certificate
    (if any) representing the Subversive Limited Partnership Units held by such Subversive Limited Partner or such other evidence of
    ownership of such Subversive Limited Partnership Units, (i) the certificates or other statements representing the Intercure Shares
    to which such Subversive Limited Partner is entitled, in accordance with its Letter of Transmittal, or (ii) confirmation of a non-certificated
    electronic position representing the Intercure Shares to which such Subversive Limited Partner is entitled, in accordance with its
    Letter of Transmittal, all in accordance with the process agreed by the Parties.
	 	 	 
	 	(c)	The
    Parties covenant and agree, as promptly as reasonably practicable after the date of this Agreement, to structure the process for
    delivering Intercure Shares to Subversive Limited Partners in order to eliminate or avoid the application of Israeli withholding
    tax (and any procedures in respect thereof) to transfers of Intercure Shares by non-Israeli residents, including by depositing the
    Intercure Shares to be issued in the Arrangement with a non-Israeli foreign stock exchange member in the United States or Canada,
    having the Intercure Shares held by a foreign broker, and taking any and all other steps reasonably necessary to eliminate such withholding
    tax.
	 	 	 
	 	(d)	Not
    later than one Business Day after the Effective Date, Intercure shall pay in cash by wire transfer in immediately available funds
    a total amount of US$100.00 to the shareholders of the General Partner for the General Partner Common Shares, and any certificates
    formerly representing common shares of the General Partner shall cease to represent any claim upon or interest in the General Partner
    other than the right of the registered holder to receive US$1.00 per share, all in accordance with the provisions of the Arrangement.

 

3.10
U.S. Tax Matters.

 

Subversive
intends to make a corporate entity classification election for U.S. Tax purposes shortly prior to the consummation of the Plan of Arrangement.
The parties acknowledge that the transaction will be reported for U.S. income tax purposes as a tax-free reorganization under U.S. Internal
Revenue Code Section 368, and the Plan of Arrangement and this Agreement together shall constitute a “plan of reorganization”
under Code Section 368 and the U.S. Treasury regulations promulgated thereunder.

 

    	-23-

     

    

 

ARTICLE
4

REPRESENTATIONS AND WARRANTIES

 

4.1
Representations and Warranties of Intercure

 

Except
as set forth in the corresponding sections of the Intercure Disclosure Schedules attached hereto (collectively, the “Intercure
Disclosure Schedules”) (each of which shall qualify only the specifically identified sections or subsections hereof to which
such Intercure Disclosure Schedule relates and shall not qualify any other provision of this Agreement), Intercure hereby represents
and warrants to Subversive and the General Partner as of the date hereof and as of the Effective Date, and acknowledges that each of
Subversive and the General Partner is relying upon such representations and warranties in connection with the entering into of this Agreement,
as follows:

 

	 	(a)	Due
    Incorporation, Intercure. Intercure has been duly incorporated and is validly existing under the laws of the State of Israel
    and is current and up-to-date with all filings required to be made by it in such jurisdiction.
	 	 	 
	 	(b)	Due
    Incorporation, Subsidiaries. Each of the Intercure Subsidiaries has been duly incorporated and is validly existing under the
    laws of its jurisdiction of formation and is current and up-to-date with all filings required to be made by it in such jurisdiction,
    and all of the issued shares in the capital of each of the Intercure Subsidiaries are owned free and clear of any pledge, lien, security
    interest, charge, claim or encumbrance or in relation to inter-corporate security.
	 	 	 
	 	(c)	Corporate
    Power. Each of Intercure and Intercure BC Sub has full corporate power, capacity and authority to undertake all steps of the
    Business Combination contemplated in the Documents and to carry out its obligations under this Agreement.
	 	 	 
	 	(d)	Share
    Capital. The authorized capital of Intercure consists of 200,000,000 Intercure Shares (prior to the Intercure Share Consolidation),
    of which, at the date hereof, there are 120,088,900 Intercure Shares issued and outstanding (prior to the Intercure Share Consolidation);
    except for such Intercure Shares and the Intercure Convertible Securities described in the Intercure Disclosure Schedules, Intercure
    has no other securities issued and outstanding at the date hereof, and the authorized capital of each Intercure Subsidiary, ownership
    thereof, and all securities convertible into or exercisable for capital of each Intercure Subsidiary, is set forth in the Intercure
    Disclosure Schedules. Except for the Intercure Subsidiaries, and the shareholdings of two life science companies described in the
    Intercure Disclosure Schedules, none of Intercure or the Intercure Subsidiaries owns any shares in the capital of any other entity.
    The Intercure BC Sub was formed for the sole purposes of effecting the Arrangement, and has no assets, business or operations.
	 	 	 
	 	(e)	Rights.
    Neither Intercure nor any one of the Intercure Subsidiaries is a party to and has not granted any agreement, warrant, option or right
    or privilege capable of becoming an agreement, for the purchase, subscription or issuance of any Intercure Shares or any shares of
    any one of the Intercure Subsidiaries, or securities convertible into or exchangeable for Intercure Shares or shares of any Intercure
    Subsidiary other than as set forth in the Intercure Disclosure Schedules.

 

    	-24-

     

    

 

	 	(f)	Permits;
    Licenses. Intercure and each of the Intercure Subsidiaries has all requisite corporate capacity, power and authority, and possesses
    all certificates, authority, permits and licenses issued by the appropriate state, provincial, municipal or federal regulatory agencies
    or bodies necessary to conduct the business as now conducted by Intercure on a consolidated basis, and to own its assets, and is
    in compliance in all material respects with such certificates, authorities, permits or licenses. Neither Intercure nor any one of
    the Intercure Subsidiaries has received any notice of proceedings relating to the revocation or modification of any such certificate,
    authority, permit or license which, singly or in the aggregate, if the subject of an unfavourable decision, order, finding or ruling,
    would adversely affect the conduct of the business, operations, financial condition, income or future prospects of Intercure on a
    consolidated basis. Neither Intercure nor any one of the Intercure Subsidiaries has any responsibility or obligation to pay any commission,
    royalty, license or similar payment to any person (other than mandatory payments to the appropriate state, provincial, municipal
    or federal regulatory agencies and applicable laws of Israel) with respect thereto.
	 	 	 
	 	(g)	Assets.

 

	 	(i)	Intercure
    and each of the Intercure Subsidiaries is the absolute legal and beneficial owner of, and has good and marketable title to, material
    property and assets necessary to conduct their businesses as currently being conducted and such material property and assets are
    free of all mortgages, liens, charges, pledges, security interests, encumbrances, claims or demands whatsoever.
	 	 	 
	 	(ii)	The
    inventory of Intercure and the Intercure Subsidiaries is merchantable and fit for the purpose for which it was procured or manufactured,
    and is not slow-moving, obsolete, damaged, or defective, subject to the reserve for inventory writedown set forth on the Balance
    Sheet as adjusted for the passage of time through the Effective Date in accordance with the past custom and practice of Intercure
    and the Intercure Subsidiaries or as would not be expected to have a Material Adverse Effect. All notes and accounts receivable of
    Intercure and the Intercure Subsidiaries are reflected properly on their books and records and are valid receivables subject to no
    setoffs or counterclaims. The accounts payable and accruals of Intercure and the Intercure Subsidiaries have arisen in bona fide
    arm’s-length transactions in the ordinary course of business, and each of Intercure and the Intercure Subsidiaries has been
    paying its accounts payable in the ordinary course.

 

	 	(h)	Due
    Authorization, Execution and Delivery. Each of the Documents has been or at the Effective Time will be, duly authorized, and
    with respect to this Agreement, executed and delivered by Intercure and the Intercure BC Sub and constitutes a valid and binding
    obligation of Intercure and the Intercure BC Sub enforceable in accordance with its terms (subject to such limitations and prohibitions
    as may exist or may be enacted in applicable laws relating to bankruptcy, insolvency, liquidation, moratorium, reorganization, arrangement
    or winding-up and other laws, rules and regulations of general application affecting the rights, powers, privileges, remedies and/or
    interests of creditors generally) and no other corporate proceeding on the part of Intercure or the Intercure BC Sub, other than
    as specified in this Agreement, is necessary to authorize this Agreement and the transactions contemplated hereby.

 

    	-25-

     

    

 

	 	(i)	Consents;
    Authorizations. The entering into and the performance by each of Intercure and the Intercure BC Sub of the Business Combination
    contemplated in the Documents: (a) do not require any consent, approval, authorization or order of any court or governmental agency,
    body or Government Authority, other than as set forth in the Intercure Disclosure Schedules; (b) will not contravene any statute
    or regulation of any Government Authority which is binding on Intercure or any of the Intercure Subsidiaries where such contravention
    would have a Material Adverse Effect; (c) will not result in the material breach of, or be in material conflict with, or constitute
    a material default under, or create a state of facts which, after notice or lapse of time, or both, would constitute a material default
    under any term or provision of the Governing Documents, by-laws or resolutions of Intercure or any of the Intercure Subsidiaries;
    and (d) except where it would not have a Material Adverse Effect, will not result in the breach of, or be in conflict with, or constitute
    a default under, or create a state of facts which, after notice or lapse of time, or both, would constitute a default under any term
    or provisions of, any material mortgage, note, indenture, contract or agreement instrument, lease or other document to which Intercure
    or any of the Intercure Subsidiaries is a party, or any judgment, decree or order or any term or provision thereof. Except for the
    requirements of the IMCA as set forth in Intercure Disclosure Schedules, there are no other restrictions on the ability of a foreign
    investor (i.e., non-Israeli) to hold interests in Intercure or in any of the Intercure Subsidiaries, and except for the IMCA requirements,
    no other approvals are required that can affect Intercure’s or any of the Intercure Subsidiaries’ operations.
	 	 	 
	 	(j)	Legal
    Proceedings. Other than as set forth in the Intercure Disclosure Schedules, there are no legal, regulatory, governmental or similar
    proceedings pending or, to the knowledge of Intercure, contemplated or threatened, to which Intercure or any one of the Intercure
    Subsidiaries is a party or to which the property of Intercure or any of the Intercure Subsidiaries is subject.
	 	 	 
	 	(k)	Insurance.
    Intercure and each of the Intercure Subsidiaries maintains valid and enforceable insurance against loss or damage in respect of its
    assets, business and operations, with responsible insurers on a basis consistent with insurance obtained by reasonably prudent participants
    in comparable businesses, including directors and officers insurance.
	 	 	 
	 	(l)	Adverse
    Legislation. Intercure is not aware of any legislation, regulations, changes or instructions from any Government Authority, which
    it anticipates will materially and adversely affect the business, affairs, operations, assets, liabilities (contingent or otherwise)
    or prospects of Intercure or the Intercure Subsidiaries.
	 	 	 
	 	(m)	Non-Competes.
    Other than as set forth in the Intercure Disclosure Schedules, and other than the requirements under the applicable laws of Israel,
    neither Intercure nor any one of the Intercure Subsidiaries is party to or bound or affected by any commitments, agreement or document
    containing any covenant which expressly limits the freedom of Intercure and the Intercure Subsidiaries to compete in any line of
    business or with any person other than for certain exclusive distribution arrangements in particular territories, or to transfer
    or move any of its assets or operations.

 

    	-26-

     

    

 

	 	(n)	Intellectual
    Property. Intercure and the Intercure Subsidiaries own and possess adequate enforceable rights to use all trademarks, patents,
    copyrights and trade secrets used or proposed to be used in the conduct of the business thereof and, to the knowledge of Intercure,
    neither Intercure nor any of the Intercure Subsidiaries is infringing upon the rights of any other person with respect to any such
    trademarks, patents, copyrights or trade secrets and, no person has infringed any such trademark, patents, copyrights or trade secrets.
	 	 	 
	 	(o)	Taxes.
    (i) Any and all taxes, duties, fees, excises, premiums, assessments, imposts, levies and other charges or assessments of any kind
    whatsoever imposed by any Government Authority, whether computed on a separate, consolidated, unitary, combined or other basis, including
    those levied on, or measured by, or described with respect to, income, gross receipts, profits, gains, windfalls, capital, capital
    stock, production, recapture, transfer, land transfer, license, gift, occupation, wealth, environment, net worth, indebtedness, surplus,
    sales, goods and services, harmonized sales, use, value-added, excise, special assessment, stamp, withholding, business, franchising,
    real or personal property, health, employee health, payroll, workers’ compensation, employment or unemployment, severance,
    social services, social security, education, utility, surtaxes, customs, import or export, and including all license and registration
    fees and all employment insurance, health insurance and government pension plan premiums or contributions; (ii) all interest, penalties,
    fines, additions to tax or other additional amounts imposed by any Government Authority on or in respect of amounts of the type described
    in clause (i) above or this clause (ii); (iii) any liability for the payment of any amounts of the type described in clauses (i)
    or (ii) as a result of being a member of an affiliated, consolidated, combined or unitary group for any period; and (iv) any liability
    for the payment of any amounts of the type described in clauses (i) or (ii) as a result of any express or implied obligation to indemnify
    any other Person or as a result of being a transferee or successor in interest to any party, in each case whether disputed or not
    (collectively, “Taxes”), due and payable by Intercure and the Intercure Subsidiaries have been paid or remitted
    or a provision made therefor, except for failure to pay such Taxes that will result in material harm to Intercure or any of the Intercure
    Subsidiaries. All tax returns, declarations, remittances and filings required to be filed by Intercure and the Intercure Subsidiaries
    have been filed with all appropriate Government Authorities and all such returns, declarations, remittances and filings are complete
    and accurate and no material fact or facts have been omitted therefrom which would make any of them misleading. To the knowledge
    of Intercure, no examination of any tax return of Intercure or any one of the Intercure Subsidiaries is currently in progress and
    except as detailed in the Intercure Disclosure Schedules, there are no issues or disputes outstanding with any Government Authority
    respecting any Taxes that have been paid, or may be payable, by Intercure and the Intercure Subsidiaries. There are no agreements
    with any taxation authority providing for an extension of time for any assessment or reassessment of Taxes with respect to Intercure
    or any of the Intercure Subsidiaries.

 

    	-27-

     

    

 

	 	(p)	Brokers.
    There is no person, firm or company acting or purporting to act at the request of Intercure who is or will be entitled to any brokerage
    or finder’s fee in connection with the transactions contemplated herein.

 

	 	(q)	Compliance
    with Law. 

 

	 	 	(i)	Intercure
    and each of the Intercure Subsidiaries has conducted and is conducting its business in compliance in all material respects with all
    applicable Laws of each jurisdiction in which it carries on business and with all Laws material to its operation, including without
    limitation all applicable antitrust laws and regulations, and neither Intercure nor any one of the Intercure Subsidiaries has received
    any notice of the revocation or cancellation of, or any intention to revoke or cancel, any of the licenses, leases or other instruments
    conferring rights to Intercure or any one of the Intercure Subsidiaries for the conduct of their business. Intercure and each of
    the Intercure Subsidiaries hold, and immediately following the Effective Time will hold, all Cannabis Licenses necessary for the
    conduct, ownership, use, occupancy or operation of their businesses or assets as conducted, owned, used, occupied or operated as
    of the date hereof, and all such Cannabis Licenses are valid and in full force and effect. To the knowledge of Intercure, the Cannabis
    Licenses will not be cancelled, terminated, revoked, limited in scope or otherwise adversely affected by the Arrangement or the other
    transactions contemplated hereby.
	 	 	 	 
	 	 	(ii)	to
    the knowledge of Intercure, all activities of Intercure and the Intercure Subsidiaries have been, up to and including the date hereof,
    conducted in compliance, in all material respects, with any and all applicable Laws, including, without limitation, Environmental
    Laws as defined below, and all applicable Laws, including of the land authority and the ministry of agriculture of Israel, the IMCA
    or any other competent authority controlling the cannabis field breeding, cultivation, harvesting, production, handling, storage,
    distribution, labeling, white labeling, sale, and possession of Cannabis, clinical trials, and the import and export of Cannabis.

 

	 	(r)	Material
    Agreements. 

 

	 	 	(i)	To
    the knowledge of Intercure, any and all material agreements pursuant to which Intercure or any one of the Intercure Subsidiaries
    holds any of their material assets or investments, or pursuant to which Intercure performs or receives services, including without
    limitation investments and joint ventures in or pertaining to non-wholly owned Subsidiaries and other Persons (each, a “Material
    Contract”), are (A) valid and subsisting agreements in full force and effect, (B) enforceable in accordance with their
    respective terms, (C) neither Intercure nor any of the Intercure Subsidiaries is in default of any of the material provisions of
    any such agreements including, without limitation, failure to fulfil any payment or work obligation thereunder nor has any such default
    been alleged, (D) Intercure is not aware of any material disputes with respect thereto, including with partners or shareholders in
    investments and joint ventures in or pertaining to non-wholly owned Subsidiaries and other Persons, and (E) such assets are in good
    standing under the applicable statutes and regulations of the jurisdictions in which they are situated, all leases, licenses and
    concessions pursuant to which Intercure and the Intercure Subsidiaries derive their interests in such material assets are in good
    standing and there has been no material default under any such leases, licenses and concessions and all real or other property taxes
    required to be paid with respect to such assets to the date hereof have been paid.

 

    	-28-

     

    

 

	 	 	(ii)	As
    of the date hereof, the Intercure Disclosure Schedules set forth a list of all Material Contracts. Other than as set forth in the
    Intercure Disclosure Schedules, there are no agreements, understandings, arrangements or other commitments, written or oral, to which
    Intercure or any Intercure Subsidiary is a party or by which it is bound which are deemed material to Intercure or any Intercure
    Subsidiary and of which Intercure is aware. Each Material Contract that is listed in the Intercure Disclosure Schedules is, to Intercure’s
    knowledge, in full force and effect (according to its terms).

 

	 	(s)	Environmental
    Laws. To the knowledge of Intercure, all the properties in which Intercure or the Intercure Subsidiaries have any freehold, leasehold,
    license or other interest are free and clear of any hazardous or toxic material, pollution, or other adverse environmental conditions
    which may give rise to any and all claims, actions, causes of action, damages, losses, liabilities, obligations, penalties, judgments,
    amounts paid in settlement, assessments, costs, disbursement or expenses (including, without limitation, attorneys’ fees and
    costs, experts’ fees and costs, and consultant’s fees and costs) of any kind or of any nature whatsoever that are asserted
    against Intercure or any of the Intercure Subsidiaries, alleging liability (including, without limitation, liability for studies,
    testing or investigatory costs, cleanup costs, response costs, removal costs, remediation costs, contaminant costs, restoration costs,
    corrective action costs, closure costs, reclamation costs, natural resource damages, property damages, business losses, personal
    injuries, penalties or fines) arising out of, based on or resulting from (i) the presence, release, threatened release, discharge
    or emission into the environment of any hazardous materials or substances existing or arising on, beneath or above properties and/or
    emanating or migrating and/or threatening to emanate or migrate from such properties to off-site properties; (ii) physical disturbance
    of the environment; and (iii) the violation or alleged violation of all applicable Laws aimed at reclamation or restoration of such
    properties; abatement of pollution; protection of the environment, protection of wildlife, including endangered species; ensuring
    public safety from environmental hazards; protection of cultural and historic resources; management, storage or control of hazardous
    materials and substances; releases or threatened releases of pollutants, contaminants, chemicals or industrial, toxic or hazardous
    substances as wastes into the environment, including without limitation, ambient air, surface water and groundwater; and all other
    applicable Laws relating to the manufacturing, processing, distribution, use, treatment, storage, disposal, handling or transport
    of pollutants, contaminants, chemicals or industrial, toxic or hazardous substances or wastes (collectively, “Environmental
    Laws”); and to the knowledge of Intercure, after due inquiry, all environmental approvals required pursuant to Environmental
    Laws with respect to activities carried out on any part of the lands covered by such properties, have been obtained, are valid and
    in full force and effect and have been complied with; and there are no proceedings commenced or threatened to revoke or amend any
    such environmental approvals.

 

    	-29-

     

    

 

	 	(t)	Related
    Party Loans. Neither Intercure nor any one of the Intercure Subsidiaries has any loan or other indebtedness outstanding which
    has been made to any of its shareholders, officers, directors or employees, past or present, or any person not dealing at “arm’s
    length” (as such term is defined in the Income Tax Act (Canada)); all such loans are described in detail in the Intercure
    Disclosure Schedules.
	 	 	 
	 	(u)	Labour
    Matters.

 

	 	(i)	The
    Intercure Disclosure Schedules set forth a list of all key employees.
	 	 	 
	 	(ii)	Other
    than as set forth in the Intercure Disclosure Schedules, neither Intercure nor any of the Intercure Subsidiaries has entered into
    an employment contract with any officer or employee or any other consultant or person or entity, which is not terminable by Intercure
    or such Intercure Subsidiary at will without liability, upon thirty (30) days prior notice.
	 	 	 
	 	(iii)	Other
    than as set forth in the Intercure Disclosure Schedules, neither Intercure nor any of the Intercure Subsidiaries has a deferred compensation
    plan or share option plan covering any of its officers or employees.
	 	 	 
	 	(iv)	Intercure
    and the Intercure Subsidiaries have complied with all applicable employment laws, policies, procedures and agreements relating to
    employment, terms and conditions of employment and to the proper withholding and remission to the proper tax and other Government
    Authorities of all sums required to be withheld from employees or persons deemed to be employees under applicable Laws respecting
    such withholding.
	 	 	 
	 	(v)	Intercure
    and the Intercure Subsidiaries have paid in full to all of their respective employees the wages, salaries, commissions, bonuses,
    benefits and other compensation due and payable to such employees on or prior to the date hereof. 
	 	 	 
	 	(vi)	Neither
    Intercure nor any of the Intercure Subsidiaries is bound by or subject to (and none of their assets or properties is bound by or
    subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union other than by way of
    any applicable employment laws and regulations and extension orders (“tzavei harchava”) applicable in its field
    of business or applicable to all employers in Israel. 
	 	 	 
	 	(vii)	Neither
    the employment by Intercure or any of the Intercure Subsidiaries of any of their respective employees, nor the engagement by them
    with any of their respective consultants, constitutes or is likely to constitute a breach of any of such Person’s obligations
    to third parties, including non-competition or confidentiality obligations. 

 

    	-30-

     

    

 

	 	(viii)	All
    persons classified by Intercure or the Intercure Subsidiaries as consultants or contractors thereof are correctly classified as such
    and not as employees for any purpose. All employees of Intercure and the Intercure Subsidiaries are subject to Section 14 Arrangement
    under the Israeli Severance Pay Law, 1963 from the commencement date of their employment and on the basis of their salary. Neither
    Intercure nor any of the Intercure Subsidiaries has any liability or obligations to pay any severance, pension, accrued vacation,
    or other social benefits and contributions, under applicable Law or contract, or any other payment of substantially the same nature,
    unless fully funded by deposit of funds in severance funds, pension funds, managers insurance policies or provident funds, or if
    not required to be so funded, adequate provisions have been made in the Financial Statements.
	 	 	 
	 	(ix)	To
    the knowledge of Intercure, there are no outstanding labour disputes, (whether filed or lodged with Intercure or any of the Intercure
    Subsidiaries or any other person or organization), pending labour disruptions or pending unionization with respect to Intercure or
    the Intercure Subsidiaries.
	 	 	 
	 	(x)	Neither
    Intercure nor any one of the Intercure Subsidiaries is bound by or a party to any collective bargaining agreement.

 

	 	(v)	Restricted
    Payments. There is not, in the Governing Documents or in any agreement, mortgage, note, debenture, indenture or other instrument
    or document to which Intercure or any one of the Intercure Subsidiaries is a party, any restriction upon or impediment to the declaration
    or payment of dividends by the directors of Intercure or the Intercure Subsidiaries or the payment of dividends by Intercure or the
    Intercure Subsidiaries to the holders of their securities.
	 	 	 
	 	(w)	Indebtedness.
    Except as disclosed in the Intercure Disclosure Schedules, neither Intercure nor any one of the Intercure Subsidiaries is party to
    any loan, bond, debenture, promissory note or other instrument evidencing indebtedness (demand or otherwise) for borrowed money (“Debt
    Instrument”) or any agreement contract or commitment to create, assume or issue any Debt Instrument.
	 	 	 
	 	(x)	Voting
    Restrictions. Neither Intercure nor any one of the Intercure Subsidiaries is a party to any agreement, nor is Intercure nor any
    one of the Intercure Subsidiaries aware of any agreement, which in any manner affects the voting control of any of the Intercure
    Shares or other securities of Intercure or the Intercure Subsidiaries.
	 	 	 
	 	(y)	Change
    in Law. Neither Intercure nor any one of the Intercure Subsidiaries is aware of any pending or contemplated change to any applicable
    Law or governmental position that would materially affect the business of Intercure or the Intercure Subsidiaries taken as a whole
    or the legal environments under which Intercure and the Intercure Subsidiaries operate.
	 	 	 
	 	(z)	No
    Material Misrepresentations or Omissions. No representation, warranty or statement of Intercure in this Agreement contains or
    will contain at the Effective Time any untrue statement of a material fact or omits or will omit to state any material fact necessary
    to make the statements contained herein or therein, in light of the circumstances under which made, not misleading.

 

    	-31-

     

    

 

	 	(aa)	Corporate
    Records. The corporate records and minute books of Intercure and the Intercure Subsidiaries contain, in all material respects,
    minutes of all meetings of the directors and shareholders since their respective dates of incorporation, together with the full text
    of all resolutions of directors and shareholders passed in lieu of such meetings, duly signed. The Intercure Disclosure Schedules
    set forth a complete list of all share registers, board registers and lien and pledge registers required by Law for Intercure and
    each Intercure Subsidiary.
	 	 	 
	 	(bb)	Due
    Diligence Sessions. The responses given by Intercure and its officers and directors in the Due Diligence Sessions were true and
    correct where they relate to matters of fact in all material respects as at the time such responses were given and at the date hereof,
    and such responses taken as a whole do not omit any fact or information necessary to make any of the responses not misleading in
    light of the circumstances in which such responses were given. Where such responses reflect the opinion or view of Intercure or such
    officers and directors (including, responses or portions of such responses, which are forward-looking or otherwise relate to projections,
    forecasts or estimates of future performance or results (operating, financial or otherwise)), such opinions or views were honestly
    held and believed to be reasonable at the time they were given and at the date hereof.
	 	 	 
	 	(cc)	Financial
    Statements. 

 

 

	 	(i)	The
    Intercure Financial Statements (including the notes thereto) (i) have been prepared in accordance with IFRS consistently applied
    throughout the periods covered thereby, (ii) present fairly in all material respects the assets, liabilities and financial condition
    of Intercure and its Subsidiaries as of such dates and the results of operations and cash flows of Intercure and its Subsidiaries
    for such periods, and (iii) are consistent with the books and records of Intercure (which books and records are accurate and complete
    in all material respects). Since the Reference Date, there has been no change in any accounting principles, policies, methods or
    practices, including any change with respect to reserves (whether for bad debt, contingent liabilities or otherwise) of Intercure
    or its Subsidiaries.
	 	 	 
	 	(ii)	Intercure
    and the Intercure Subsidiaries do not have any liabilities, that would have been required by IFRS to be reflected in, reserved against
    or otherwise described in a consolidated balance sheet, except (a) as and to the extent specifically accrued for or reserved against
    in the consolidated balance sheet of Intercure and its Subsidiaries as of September 30, 2020 (the “Balance Sheet”),
    (b) liabilities which have arisen after the date of the Balance Sheet in the ordinary course (none of which results from, arises
    out of, relates to, is in the nature of, or was caused by any breach of contract, breach of warranty, tort, infringement or violation
    of Law), (c) executory obligations under contracts (other than liabilities relating to any breach, or any fact or circumstance that,
    with notice, lapse of time or both, would result in a breach, thereof by Intercure or any Intercure Subsidiary), and (d) liabilities
    specifically set forth in the Intercure Disclosure Schedules.

 

    	-32-

     

    

 

	 	(dd)	Conduct
    of Business. Since September 30, 2020 (the “Reference Date”), (a) each of Intercure and the Intercure Subsidiaries
    has conducted its business only in the ordinary course; (b) no event has occurred that, individually or in combination with any other
    events, has had or would reasonably be expected to have Material Adverse Effect; and (c) none of Intercure and the Intercure Subsidiaries
    has suffered any loss, damage, destruction or other casualty affecting any of its material properties or assets, whether or not covered
    by insurance.
	 	 	 
	 	(ee)	Customers.
    The Intercure Disclosure Schedules contains a complete and accurate list of the ten (10) largest customers to Intercure and the Intercure
    Subsidiaries, taken as a whole, (consolidating into a single customer all affiliated customers) by the aggregate dollar value of
    revenue received by Intercure and the Intercure Subsidiaries, taken as a whole, during the twelve month period ended December 31,
    2020 (each a “Top Customer”). Since September 30, 2020, no Top Customer has terminated or adversely modified the
    amount, pricing, frequency or terms of the business such Top Customer conducts with Intercure or any Intercure Subsidiary. Neither
    Intercure nor any Intercure Subsidiary has received any written notice, nor does Intercure have knowledge, that any Top Customer
    will terminate or adversely modify the amount, pricing, frequency or terms of the business such Top Customer conducts with Intercure
    or any Intercure Subsidiary. There is no material dispute pending with any Top Customer, and neither Intercure nor any Intercure
    Subsidiary has received any written notice, nor does Intercure have any knowledge, of a reasonable basis for any such dispute.
	 	 	 
	 	(ff)	Suppliers.
    The Intercure Disclosure Schedules contains a complete and accurate list of (i) the ten (10) largest suppliers to Intercure and the
    Intercure Subsidiaries, taken as a whole, (excluding utilities) by the aggregate dollar value of purchases by Intercure and the Intercure
    Subsidiaries, taken as a whole, during the twelve month period ended December 31, 2020 (each a “Top Supplier”).
    Since September 30, 2020, no Top Supplier has terminated or adversely modified the amount, pricing, frequency or terms of the business
    such Top Supplier conducts with Intercure or any Intercure Subsidiary. Neither Intercure nor any Intercure Subsidiary has received
    any written notice, nor does Intercure have knowledge, that any Top Supplier will terminate or adversely modify the amount, pricing,
    frequency or terms of the business such Top Supplier conducts with Intercure or any Intercure Subsidiary. There is no material dispute
    pending with any Top Supplier, and neither Intercure nor any Intercure Subsidiary has received any written notice, nor does Intercure
    have any knowledge, of a reasonable basis for any such dispute.
	 	 	 
	 	(gg)	Related
    Party. No Related Party has any direct or indirect interest in (a) any Top Customer or Top Supplier or (b) any assets or property
    used by Intercure or any Intercure Subsidiary (including any intellectual property). The Intercure Disclosure Schedules sets forth
    the parties to and the date, nature and amount of each Related Party Transaction since the Reference Date (other than salary or other
    compensation or benefits paid or payable in the ordinary course of business consistent with past practice to employees in consideration
    for bona fide services performed by such employees).

 

    	-33-

     

    

 

	 	(hh)	Real
    Property.

 

	 	(i)	The
    Intercure Disclosure Schedules sets forth a complete list, including an address of each leasehold or subleasehold estate or other
    right to use or occupy any interest in real property held by Intercure or any Intercure Subsidiary (“Leased Real Property”)
    and the Real Property Leases (including all amendments, guaranties and other agreements with respect thereto) relating to each
    such Leased Real Property. With respect to each Leased Real Property, (i) Intercure’s or the relevant Intercure Subsidiary’s
    (as applicable) possession and quiet enjoyment under the applicable Real Property Lease has not been disturbed, and nor does Intercure
    have knowledge of any disputes with respect to any Real Property Lease, (ii) neither Intercure nor any Intercure Subsidiary has subleased,
    licensed or otherwise granted any person the right to use or occupy any Leased Real Property or any portion thereof, or collaterally
    assigned or granted any security interest in such Leased Real Property or any interest therein and (iii) there are no special, general
    or other assessments pending against Intercure or any Intercure Subsidiary or affecting any Leased Real Property that would be payable
    by the lessee thereof. Neither Intercure nor any Intercure Subsidiary or any other party to a Real Property Lease is or has been
    in breach or default under such Real Property Lease, and no event has occurred or circumstance exists which, with the delivery of
    notice, the passage of time or both, would constitute such a breach or default, or permit the termination, modification, or acceleration
    or increase of rent under such Real Property Lease. No security deposit or portion thereof deposited with respect to any Real Property
    Lease has been applied in respect of a breach or default under any Real Property Lease which has not been redeposited in full. Neither
    Intercure nor any Intercure Subsidiary owes, or will owe in the future, any brokerage commissions or finder’s fees with respect
    to any Real Property Lease.
	 	 	 
	 	(ii)	The
    Leased Real Property comprises all of the real property that is used in or otherwise related to the businesses of Intercure and each
    Intercure Subsidiary. To the knowledge of Intercure, all buildings, structures, improvements, fixtures, building systems (including
    HVAC, electrical, plumbing and sewer systems) and equipment, and all components thereof, included in the Leased Real Property (collectively,
    “Improvements”) are in good condition and repair and are sufficient for the operation of the businesses of Intercure
    and each Intercure Subsidiary as currently conducted. To the knowledge of Intercure, there are no structural deficiencies or latent
    defects affecting any of the Improvements and, there are no facts or conditions affecting any of the Improvements which would, individually
    or in the aggregate, interfere in any respect with the use or occupancy of the Improvements or any portion thereof in the operation
    of the business conducted thereon. Neither Intercure nor any Intercure Subsidiary has received any written notice from any insurance
    company or board of fire underwriters of any defects or inadequacies that could adversely affect the insurability of any Leased Real
    Property or requesting the performance of any work or alteration with respect to any Leased Real Property. To the knowledge of Intercure,
    there is no pending or threatened condemnation, expropriation or other governmental taking of any part or interest in any Leased
    Real Property. The current and intended use and occupancy of the Leased Real Property and the operation of Intercure’s and
    each Intercure Subsidiary’s businesses as currently conducted do not violate any applicable zoning law, easement, covenant,
    condition, restriction or similar provision in any instrument of record affecting the Leased Real Property. To the knowledge of Intercure,
    no fact or condition exists that could result in the termination or impairment of presently available access from adjoining public
    or private streets or ways or in the discontinuation of presently available sewer, water, electric, gas, telephone or other utilities
    or services for any Leased Real Property.

 

    	-34-

     

    

 

	 	(ii)	Cannabis
    Matters. All products manufactured, processed, marketed, distributed, sold or delivered by Intercure or any Intercure Subsidiary
    have been in conformity with all applicable warranties, and neither Intercure nor any Intercure Subsidiary has any material liability
    for replacement thereof or other material damages in connection therewith in excess of any warranty reserve established with respect
    thereto on the Balance Sheet as adjusted for the passage of time through the Effective Date in accordance with the past custom and
    practice of Intercure and the Intercure Subsidiaries. Each product manufactured, sold or delivered by Intercure and the Intercure
    Subsidiaries is in compliance in all material respects with all applicable Laws controlling the cultivation, harvesting, production,
    handling, storage, distribution, sale, and possession of Cannabis. Any products sold by Intercure or the Intercure Subsidiaries that
    were purchased by Intercure or an Intercure Subsidiary from a third parties was, to the knowledge of Intercure, cultivated, harvested,
    produced, tested, handled and delivered in accordance with all applicable Law in all material respects, and were purchased from suppliers
    duly licensed to cultivate, harvest and produce such products. The breeding, cultivation, harvesting, production, storage, distribution
    import, export and sale of medical cannabis in Israel is permitted by applicable Law. Neither Intercure nor any Intercure Subsidiary
    has used any substance, including pesticides, prohibited by Laws applicable in the states and localities in which such Person operates,
    in any prohibited amount at any stage of the cultivation, harvesting, handling, storage or delivery of such products. Intercure and
    the Intercure Subsidiaries have performed (or caused to be performed by third parties) all material and necessary tests and obtained
    all test certificates and certificates of ingredients required by applicable Law, including tests for microbials, contaminants, residuals,
    and pesticides, with respect to any product manufactured, sold or delivered by Intercure or such Intercure Subsidiary. To the knowledge
    of Intercure, no products manufactured, sold or delivered by Intercure contain any prohibited pesticides, contaminants or any other
    substance prohibited by any Law. Neither Intercure nor any Intercure Subsidiary has received any written notice of any claims for,
    and to Intercure’s knowledge there is no reasonable basis for, any extraordinary product recalls relating to any of its products
    or services. Neither Intercure nor any Intercure Subsidiary has had or has any material liability arising out of any injury to individuals
    or property as a result of the ownership, possession or use of any products manufactured, sold or delivered by Intercure or any Intercure
    Subsidiary or with respect to any services rendered by Intercure or any Intercure Subsidiary. Intercure and the Intercure Subsidiaries
    are in material compliance with all applicable advertising or labeling requirements that prohibit “drug” claims on products
    that have not received the appropriate drug approval. Intercure and the Intercure Subsidiaries are in material compliance with all
    applicable advertising or labeling requirements that prohibit “drug” claims on products that have not received the appropriate
    drug approval.

 

    	-35-

     

    

 

	 	(jj)	Information.
    None of the information or financial statements relating to Intercure and any Intercure Subsidiary included or to be included in
    the Information Circular, the Prospectus, the U.S. Registration Statement or the U.S. Resale Registration Statement, or that have
    been and will be included in any information statement or proxy statement relating to the Business Combination do or will contain
    any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein not misleading
    and, in respect of the Information Circular, Prospectus, the U.S. Registration Statement or the U.S. Resale Registration Statement,
    as applicable, will constitute full, true and plain disclosure of all material facts relating to Intercure and the Intercure Subsidiaries
    as required by applicable Securities Laws.
	 	 	 
	 	(kk)	Public
    Filings. Intercure has filed or furnished to the TASE and the ISA, in the 36 months preceding the Effective Date, all reports,
    schedules, forms, statements and other documents required to be filed with or furnished under the Israeli Securities Law 5728-1968
    and the regulations promulgated thereunder (the “Filed Documents”), on a timely basis or has received a valid
    extension of such time of filing and has filed any such Filed Documents prior to the expiration of any such extension. All of the
    Filed Documents have been prepared in accordance with the Israeli Securities Law and, subject to the foregoing, each of the Filed
    Documents (including the financial statements or schedules included therein) as of the respective date of filing, did not contain
    any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made therein,
    in light of the circumstances under which they were made, not misleading.
	 	 	 
	 	(ll)	Privacy
    and Information Security. Intercure and each Intercure Subsidiary is and has been in material compliance with (a) all Privacy
    and Information Security Requirements, (b) its internal and external privacy policies and notices and (c) all contracts relating
    to the Processing of Personal Data. Neither Intercure nor any Intercure Subsidiary, nor to Intercure’s knowledge, any other
    Person, has received any written notice, allegation, complaint or other communication, and, to Intercure’s knowledge, there
    is no pending investigation by any Governmental Authority or payment card association, regarding any actual or alleged violation
    of any Privacy and Information Security Requirement by or with respect to Intercure or any Intercure Subsidiary. To Intercure’s
    knowledge, neither Intercure nor any Intercure Subsidiary has suffered a security breach with respect to any of the Intercure Data
    and there has been no unauthorized or illegal use of or access to any Intercure Data. Neither Intercure nor any Intercure Subsidiary
    has notified, or, to Intercure’s knowledge, has been required to notify, any Person of any information security breach involving
    Personal Data. Intercure and each Intercure Subsidiary employs and has employed commercially reasonable security measures that materially
    comply with all Privacy and Information Security Requirements and are designed to protect Intercure Data within its custody or control
    and requires the same of all vendors that Process Intercure Data on its behalf. Intercure and each Intercure Subsidiary has provided
    all requisite notices and obtained all required consents, and satisfied all other requirements (including to notify Governmental
    Authorities) to the extent required under the Privacy and Information Security Requirements for such Person’s Processing (including
    international and onward transfer) of all Personal Data in connection with the conduct of the business of Intercure or such Intercure
    Subsidiary. The execution, delivery, performance and consummation of the transaction contemplated hereunder comply with Intercure’s
    and each Intercure Subsidiary’s applicable Privacy and Information Security Requirements.
	 	 	 
	 	(mm)	Disclosure.
    Intercure has provided Subversive with all materials and information responsive to all due diligence requests made by Subversive,
    and none of such information contains any untrue statement of a material fact or omits a material fact necessary to make such information
    incomplete or misleading.

 

    	-36-

     

    

 

	4.2	Representations
    and Warranties of Subversive

 

Except
as set forth in the corresponding sections of the Subversive Disclosure Schedules attached hereto (collectively, the “Subversive
Disclosure Schedules”) (each of which shall qualify only the specifically identified sections or subsections hereof to which
such Subversive Disclosure Schedule relates and shall not qualify any other provision of this Agreement), Subversive hereby represents
and warrants to Intercure as of the date hereof and as of the Effective Date, and acknowledges that Intercure is relying upon such representations
and warranties in connection with the entering into of this Agreement, as follows:

 

	 	(a)	Due
    Formation. Subversive is a validly existing limited partnership under the laws of the Province of Ontario and is registered to
    carry on business under the laws of each jurisdiction in which it carries on its business.
	 	 	 
	 	(b)	Power.
    Subversive through the General Partner has full power, capacity and authority to undertake all steps of the Business Combination
    contemplated in the Documents and to carry out its obligations under this Agreement.
	 	 	 
	 	(c)	Share
    Capital. The authorized capital of Subversive consists of (i) an unlimited number of Subversive Restricted Voting Units, of which
    22,500,000 Subversive Restricted Voting Units are currently issued and outstanding (ii) an unlimited number of Subversive Class B
    Units, of which 524,500 Subversive Class B Units are currently issued and outstanding, (iii) an unlimited number of Subversive Proportionate
    Voting Units, of which 57,562 Subversive Proportionate Voting Units (not taking into account the Subversive Proportionate Voting
    Units underlying the Class B Units) are currently issued and outstanding, and (iv) one general partnership unit, which is currently
    issued and outstanding; except for the 23,024,500 Subversive Rights, Subversive has no other securities outstanding nor is it a party
    to or has granted any agreement, warrant, option or right or privilege capable of becoming an agreement, for the purchase, subscription
    or issuance of any Subversive Restricted Voting Unit or Subversive Class B Unit or securities convertible into or exchangeable for
    any Subversive Class A Restricted Voting Unit or Subversive Class B Unit.
	 	 	 
	 	(d)	Reporting
    Issuer. Subversive is a reporting issuer, or the equivalent thereof, in each of the provinces and territories of Canada (other
    than Quebec) (collectively, the “Reporting Jurisdictions”) and is not currently in default of any requirement
    of the applicable laws of each of the Reporting Jurisdictions and other regulatory instruments of the Subversive Securities Authorities,
    and no order ceasing, halting or suspending trading in securities of Subversive or prohibiting the distribution of such securities
    has been issued to and is outstanding against Subversive and no investigations or proceedings for such purposes are, to the knowledge
    of Subversive, pending or threatened.

 

    	-37-

     

    

 

	 	(e)	Compliance
    with Law. Subversive is in compliance in all material respects with all its disclosure obligations under applicable Laws and
    all documents filed by Subversive pursuant to such obligations are in compliance in all material respects with applicable Laws and,
    other than in respect of documents that have been amended or refiled did not contain any untrue statement of a material fact or omit
    to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
    under which they were made, not misleading.
	 	 	 
	 	(f)	Subsidiaries.
    Subversive has no Subsidiaries other than the Subversive Subsidiaries, and is not a partner, co-tenant, joint venturer or otherwise
    a participant in any partnership, joint venture, co-tenancy or other similarly joint owned business.
	 	 	 
	 	(g)	Permits;
    Licenses. Subversive has all requisite limited partnership capacity, power and authority, and possesses all material certificates,
    authority, permits and licenses issued by the appropriate state, provincial, municipal or federal regulatory agencies or bodies necessary
    to conduct the business as now conducted by it and to own its assets and is in compliance in all material respects with such certificates,
    authorities, permits or licenses. Subversive has not received any notice of proceedings relating to the revocation or modification
    of any such certificate, authority, permit or license which, singly or in the aggregate, if the subject of an unfavourable decision,
    order, finding or ruling, would materially and adversely affect the conduct of the business, operations, financial condition, income
    or future prospects of Subversive.
	 	 	 
	 	(h)	Due
    Authorization, Execution and Delivery. Each of the Documents has been, or at the Effective Time will be, duly authorized and,
    with respect to this Agreement, executed and delivered by Subversive and constitutes a valid and binding obligation of Subversive
    enforceable in accordance with its terms (subject to such limitations and prohibitions as may exist or may be enacted in applicable
    laws relating to bankruptcy, insolvency, liquidation, moratorium, reorganization, arrangement or winding-up and other laws, rules
    and regulations of general application affecting the rights, powers, privileges, remedies and/or interests of creditors generally)
    and no other limited partnership proceeding on the part of Subversive, is necessary to authorize this Agreement and the transactions
    contemplated hereby.
	 	 	 
	 	(i)	Consents;
    Authorizations. the entering into and the performance by Subversive of the transactions contemplated in the Documents:

 

	 	(i)	do
    not require any consent, approval, authorization or order of any court or governmental agency or body, except that which may be required
    under applicable corporate and securities legislation and the policies of the Exchange;
	 	 	 
	 	(ii)	will
    not contravene any statute or regulation of any Government Authority which is binding on Subversive where such contravention would
    have a Material Adverse Effect; and

 

    	-38-

     

    

 

	 	(iii)	will
    not result in the material breach of, or be in conflict with, or constitute a material default under, or create a state of facts
    which, after notice or lapse of time, or both, would constitute a material default under any term or provision of the Governing Documents
    or resolutions of Subversive or any mortgage, note, indenture, contract or agreement, instrument, lease or other document to which
    Subversive is or will be a party, or any judgment, decree or order or any term or provision thereof, which breach, conflict or default
    would have a Material Adverse Effect.

 

	 	(j)	Legal
    Proceedings. There are no legal or governmental proceedings pending or, to the knowledge of Subversive, contemplated or threatened,
    to which Subversive is a party or to which the assets or property of Subversive is subject.
	 	 	 
	 	(k)	Financial
    Statements.

 

	 	 	(i)	The
    audited financial statements of Subversive for the period from inception (the date of formation) through December 31, 2019 and the
    notes thereto (collectively, the “Subversive Financial Statements”), have been prepared in accordance with IFRS,
    present fairly, in all material respects, the financial position of Subversive as of such date, and do not omit to state any material
    fact that is required by IFRS or by applicable law to be stated or reflected therein or which is necessary to make the statements
    contained therein not misleading.
	 	 	 	 
	 	 	(ii)	Neither
    Subversive nor any one of the Subversive Subsidiaries has any outstanding material liability, whether direct, indirect, absolute
    or contingent or otherwise, which is not reflected in the Subversive Financial Statements.

 

	 	(l)	Related
    Party. Except as disclosed in the Subversive Financial Statements, Subversive has not engaged in any transaction with any person
    that it is not dealing with at “arm’s length” (as such term is defined in the Income Tax Act (Canada)) since
    the beginning of the period covered by the Subversive Financial Statements.
	 	 	 
	 	(m)	Taxes.
    All Taxes due and payable by Subversive have been paid or provision made therefor in the financial statements of Subversive except
    for where the failure to pay such Taxes would not result in a Material Adverse Effect for Subversive. All tax returns, declarations,
    remittances and filings required to be filed by Subversive have been filed with all appropriate Government Authorities and all such
    returns, declarations, remittances and filings are complete and accurate and no material fact or facts have been omitted therefrom
    which would make any of them misleading. To the knowledge of Subversive, no examination of any tax return of Subversive is currently
    in progress and there are no issues or disputes outstanding with any Government Authority respecting any Taxes that have been paid,
    or may be payable, by Subversive. There are no agreements with any taxation authority providing for an extension of time for any
    assessment or reassessment of Taxes with respect to Subversive.
	 	 	 
	 	(n)	Brokers.
    Other than (i) the fees paid and payable to the underwriters in connection with the initial public offering of Subversive and in
    connection with the transactions contemplated herein, as disclosed in the Final IPO Prospectus, or (ii) to agents or advisors for
    services provided in connection with the qualifying transactions, as set forth on Section 4.2(o) of the Subversive Disclosure
    Schedules, there is no person, firm or company acting or purporting to act at the request of Subversive who is entitled to any brokerage
    or finder’s fee in connection with the transactions contemplated in the Documents.

 

    	-39-

     

    

 

	 	(o)	Compliance
    with Laws. Other than any non-compliance which would not result in a Material Adverse Effect in respect of Subversive, to the
    knowledge of Subversive, after due inquiry all activities of Subversive have been, up to and including the date hereof, conducted
    in compliance, in all material respects, with any and all applicable Laws.
	 	 	 
	 	(p)	Qualifying
    Transaction. The Business Combination will satisfy the requirements of section 10.16(15) of the Exchange Listing Manual.

 

	4.3	Representations
    and Warranties of the General Partner

 

The
General Partner hereby represents and warrants to Intercure as of the date hereof and as of the Effective Date, and acknowledges that
Intercure is relying upon such representations and warranties in connection with the entering into of this Agreement, as follows:

 

	 	(a)	Due
    Formation. The General Partner is a validly existing corporation under the laws of the Province of Ontario and is registered
    to carry on business under the laws of each jurisdiction in which it carries on its business.
	 	 	 
	 	(b)	Power.
    The General Partner has full power, capacity and authority to undertake all steps of the Business Combination contemplated in the
    Documents and to carry out its obligations under this Agreement.
	 	 	 
	 	(c)	Share
    Capital. The authorized capital of the General Partner consists of one hundred (100) common shares.
	 	 	 
	 	(d)	Due
    Authorization, Execution and Delivery. Each of the Documents has been, or at the Effective Time will be, duly authorized and,
    with respect to this Agreement, executed and delivered by the General Partner and constitutes a valid and binding obligation of the
    General Partner enforceable in accordance with its terms (subject to such limitations and prohibitions as may exist or may be enacted
    in applicable laws relating to bankruptcy, insolvency, liquidation, moratorium, reorganization, arrangement or winding-up and other
    laws, rules and regulations of general application affecting the rights, powers, privileges, remedies and/or interests of creditors
    generally) and no other corporate proceeding on the part of the General Partner, is necessary to authorize this Agreement and the
    transactions contemplated hereby.
	 	 	 
	 	(e)	Consents;
    Authorizations. the entering into and the performance by the General Partner of the transactions contemplated in the Documents:

 

	 	(i)	do
    not require any consent, approval, authorization or order of any court or governmental agency or body, except that which may be required
    under applicable corporate and securities legislation and the policies of the Exchange;

 

    	-40-

     

    

 

	 	(ii)	will
    not contravene any statute or regulation of any Government Authority which is binding on Subversive where such contravention would
    have a Material Adverse Effect; and
	 	 	 
	 	(iii)	will
    not result in the material breach of, or be in conflict with, or constitute a material default under, or create a state of facts
    which, after notice or lapse of time, or both, would constitute a material default under any term or provision of the Governing Documents
    or resolutions of Subversive or any mortgage, note, indenture, contract or agreement, instrument, lease or other document to which
    Subversive is or will be a party, or any judgment, decree or order or any term or provision thereof, which breach, conflict or default
    would have a Material Adverse Effect.

 

	4.4	Survival

 

For
greater certainty, subject to the Indemnification Agreement, the representations and warranties of each of the Parties contained herein
shall survive the execution and delivery of this Agreement and shall terminate and be extinguished on the earlier of the termination
of this Agreement in accordance with its terms and the Effective Time; provided, however, that the Fundamental Representations shall
survive indefinitely.

 

ARTICLE
5

COVENANTS

 

	5.1	Conduct
    of Business by the Parties

 

Except
as required by Law or as otherwise expressly permitted or specifically contemplated by this Agreement, each Party covenants and agrees
that, during the period from the date of this Agreement until the earlier of either the Effective Time or the time that this Agreement
is terminated by its terms, unless each of the other Parties shall otherwise agree in writing it shall, and shall cause its Subsidiaries
to conduct business in, and not take any action except in, the usual and ordinary course of business, with the exception of reasonable
costs incurred in connection with the Business Combination, and it shall and shall cause its Subsidiaries to use all commercially reasonable
efforts to maintain and preserve its business organization, assets, employees and advantageous business relationships and it shall not,
and shall cause its Subsidiaries to not, without the prior written consent of the other Parties, enter into any contract in respect of
its business or assets, other than in the ordinary course of business, and without limitation but subject to the foregoing, shall maintain
payables and other liabilities at levels consistent with past practice, shall not engage or commit to engage in any extraordinary material
transactions and shall not make or commit to make distributions, dividends or special bonuses, without the prior written consent of the
other Parties.

 

	5.2	Representations
    and Warranties

 

	 	(a)	Intercure
    covenants and agrees that from the date hereof until the termination of this Agreement it shall not take any action, or fail to take
    any action, which would or may reasonably be expected to result in the representations and warranties set out in Section 4.1
    being untrue in any material respect.
	 	 	 
	 	(b)	Subversive
    covenants and agrees that, from the date hereof until the termination of this Agreement it shall not take any action, or fail to
    take any action, which would or may reasonably be expected to result in the representations and warranties set out in Section
    4.2 being untrue in any material respect.

 

    	-41-

     

    

 

	 	(c)	The
    General Partner covenants and agrees that, from the date hereof until the termination of this Agreement it shall not take any action,
    or fail to take any action, which would or may reasonably be expected to result in the representations and warranties set out in
    Section 4.2 being untrue in any material respect.

 

	5.3	Notice
    of Material Change

 

	 	(a)	From
    the date hereof until the termination of this Agreement, each Party shall promptly notify the other Party in writing of:

 

	 	(i)	any
    material change (actual, anticipated, contemplated or, to the knowledge of such Party or any of its Subsidiaries, threatened, financial
    or otherwise) in the business, affairs, operations, assets, liabilities (contingent or otherwise) or capital of such Party and its
    Subsidiaries, taken as whole;
	 	 	 
	 	(ii)	any
    change in the facts relating to any representation or warranty set out in Sections 4.1 or 4.2 hereof, as applicable,
    which change is or may be of such a nature as to render any such representation or warranty misleading or untrue in a material respect;
    or
	 	 	 
	 	(iii)	any
    material fact which arises and which would have been required to be stated herein had the fact arisen on or prior to the date of
    this Agreement.

 

	 	(b)	Each
    of the Parties shall in good faith discuss with the other any change in circumstances (actual, anticipated, contemplated or, to its
    knowledge of its or any of its Subsidiaries, threatened, financial or otherwise) which is of such a nature that there may be a reasonable
    question as to whether notice need to be given to the other pursuant to this Section.

 

	5.4	Non-Solicitation

 

	 	(a)	None
    of the Parties shall solicit any offers to purchase their respective shares or assets, or any portion above 5% thereof, and neither
    Subversive nor Intercure will, directly or indirectly, initiate, enter into or encourage any discussions or negotiations with any
    third party with respect to such a transaction or amalgamation, merger, take-over, plan of arrangement or similar transaction or
    a Going Public Transaction other than for this Business Combination during the period commencing on the date hereof and ending on
    the termination of this Agreement. The Parties shall immediately cease and cause to be terminated any existing discussions or negotiations
    with any third party related to any of the foregoing. In the event any of the Parties is approached in respect of any such transaction,
    it shall immediately notify the other.
	 	 	 
	 	(b)	Notwithstanding
    this Section 5.4 and any other provision of this Agreement, any Intercure Shareholder shall, for greater certainty, have the
    right to sell, transfer and assign its Intercure Shares to any other Intercure Shareholder or to any officer and/or director of Intercure
    subject to any applicable Laws.

 

    	-42-

     

    

 

	5.5	Mutual
    Negative Covenants

 

Each
Party agrees that, from the date hereof until the earlier of the termination of this Agreement and the completion of the Arrangement,
it shall not directly or indirectly do, permit to occur, authorize or agree to any of the following, other than to the extent required
by the terms of this Agreement or the Plan of Arrangement:

 

	 	(a)	issue,
    grant, sell or pledge or agree to issue, grant, sell or pledge any shares, or securities convertible into or exchangeable or exercisable
    for, or otherwise evidencing a right to acquire shares, including of any Subsidiary, other than:

 

	 	(i)	in
    the case of Intercure:

 

	 	 	(A)	in
    connection with the Arrangement;
	 	 	 	 
	 	 	(B)	the
    issuance of Intercure Shares and/or warrants upon the exercise of any Intercure Convertible Securities;
	 	 	 	 
	 	 	(C)	the
    grant of up to 4,303,356 Intercure Options (prior to the Intercure Share Consolidation) and other similar issuances pursuant to the
    Plan to directors, officers, employees or consultants, provided that any Intercure Option grants in excess of such 4,303,356 Intercure
    Options (prior to the Intercure Share Consolidation) must be exercisable at a price of not less than $1.30, per Intercure Share on
    a pre-Arrangement basis; and

 

	 	(ii)	in
    the case of Subversive,

 

	 	 	(A)	in
    connection with the Business Combination, including the issuance of 500,000 Subversive Limited Partnership Units to underwriters
    due as a result of consummation of the Qualifying Transaction; and
	 	 	 	 
	 	 	(B)	the
    issuance of Subversive Restricted Voting Units or Subversive Limited Partnership Units upon the exercise of any Subversive Rights;

 

	 	(b)	except
    as otherwise described in the Final IPO Prospectus (and specifically in relation with a redemption event as described therein), redeem,
    purchase or otherwise acquire any of its outstanding shares or other securities including, without limitation, under an issuer bid;
	 	 	 
	 	(c)	adopt
    a plan of liquidation or resolutions providing for the liquidation, dissolution, merger, consolidation or reorganization of itself
    or any of its Subsidiaries, except for the Business Combination or as otherwise contemplated in this Agreement;
	 	 	 
	 	(d)	borrow
    any cash or incur any indebtedness, except as expressly contemplated by this Agreement or with the prior written consent of the other
    Parties and, in the case of Intercure, Intercure shall be permitted, without any prior consent of the other Parties, to: (A) incur
    trade payables in the ordinary course; and (B) borrow amounts not to exceed $1,000,000 in the aggregate;

 

    	-43-

     

    

 

	 	(e)	make
    loans, advances or other similar payments to any third party except as expressly contemplated by this Agreement and, in the case
    of Intercure, Intercure shall be permitted to (A) make routine advances to Intercure employees for expenses incurred in the ordinary
    course; or (B) as consented to by Subversive, which consent shall not be unreasonably withheld;
	 	 	 
	 	(f)	declare,
    set aside or pay any dividend or other distribution or payment (whether in cash, shares or property) in respect of its shares owned
    by any Person other than inter-corporate loans and advances and except for the Business Combination or as otherwise contemplated
    by this Agreement;
	 	 	 
	 	(g)	amend
    its Governing Documents or otherwise split, combine or reclassify any of its shares in any manner which may adversely affect the
    success of the Business Combination, except as required by the Business Combination or to give effect to the matters contemplated
    in this Agreement;
	 	 	 
	 	(h)	enter
    into any transaction or material contract, except in the case of the transactions contemplated by the Business Combination; and
	 	 	 
	 	(i)	engage
    in any business enterprise or activity different from that carried on as of the date hereof, without the prior written consent of
    the other Parties.

 

	5.6	Intercure
    Negative Covenants

 

Intercure
agrees that, from the date hereof until the earlier of the termination of this Agreement and the completion of the Arrangement, it shall
not directly or indirectly do, permit to occur, authorize or agree to any of the following:

 

	 	(a)	sell,
    transfer, deliver, lease, license, sublicense, mortgage, pledge, encumber, impair or otherwise dispose of (in whole or in part),
    or create, incur, suffer to exist, assume or cause to be subjected to any lien on or abandon, cancel or allow to lapse, any of the
    material assets, rights or properties of Intercure or any Intercure Subsidiary (including any intellectual property or accounts receivable),
    except for sales of inventory or non-exclusive licenses of intellectual property in the ordinary course;
	 	 	 
	 	(b)	amend,
    waive, release or terminate any Material Contract (other than terminations upon any expiration of the terms of any Material Contract
    in the ordinary course);
	 	 	 
	 	(c)	(A)
    increase the compensation or fringe benefits of any employee (except for increases in salary for employees with annual compensation
    of less than $200,000 in the ordinary course), (B) hire or offer to hire any new employees with annual compensation in excess of
    $200,000 or terminate or encourage any employee to resign from Intercure or an Intercure Subsidiary other than in the Ordinary Course,
    (C) grant any severance or termination pay (in cash or otherwise) to any current or former employee, except pursuant to any contract
    or employee benefit plan in effect on the date hereof in connection with the termination of any such employee or increase in severance
    or termination pay, or (D) establish, adopt, enter into, materially amend or terminate (or grant any waiver or consent under) any
    employee benefit plan, except for any amendments required by applicable Law,

 

    	-44-

     

    

 

	 	(d)	enter
    into or amend any collective bargaining agreement or contract with any labour union or other labour organization;
	 	 	 
	 	(e)	make
    any change to its methods of accounting or accounting practices, policies or procedures (including with respect to reserves, revenue
    recognition, inventory control, prepayment of expenses, timing for payments of accounts payable and collection of accounts receivable),
    except as required by IFRS or applicable Law;
	 	 	 
	 	(f)	(A)
    make or change any material Tax election or change any method of tax accounting, (B) settle or compromise any material Tax liability,
    (C) file any material amended Tax return, (D) enter into any closing agreement relating to any Tax, (E) agree to an extension of
    a statute of limitations with respect to Taxes, or (F) surrender any right to claim a Tax refund in any case that would reasonably
    be expected to be material;
	 	 	 
	 	(g)	other
    than in the ordinary course, commence, make payment with respect to, discharge, satisfy, settle or otherwise compromise any legal
    proceeding or waive, assign or release any material rights or claims (other than legal proceedings arising out of this Agreement);
	 	 	 
	 	(h)	commence,
    settle, compromise or otherwise resolve any legal proceeding or waive, assign or release any material rights or claims, except (A)
    with respect to routine matters in the ordinary course, (B) in such cases where Intercure reasonably determines in good faith that
    the failure to take any such action with respect to such legal proceeding would result in a material impairment of its rights with
    respect thereto, provided that Intercure consults with Subversive prior to commencing such Proceeding or (C) any legal proceeding
    arising out of this Agreement;
	 	 	 
	 	(i)	other
    than as permitted under subsection (c) above, engage in, enter into or modify or amend any agreement, contract, transaction or other
    arrangement with, directly or indirectly, any Related Party;
	 	 	 
	 	(j)	terminate,
    amend or fail to renew or preserve any material permit, license or governmental authorization;
	 	 	 
	 	(k)	terminate,
    amend, fail to renew or preserve, or permit to lapse or enter the public domain, any material intellectual property, except for amendments
    to registered or applied for intellectual property completed in the ordinary course of business consistent with past practice;
	 	 	 
	 	(l)	permit
    the lapse of any existing material insurance policy relating to the business or assets of Intercure or any Intercure Subsidiary;
	 	 	 
	 	(m)	make
    any material changes in Intercure’s or any Intercure Subsidiary’s practices and policies relating to manufacturing, purchasing,
    inventory management, marketing, selling or pricing, except in the ordinary course; and
	 	 	 
	 	(n)	take
    or omit to take any action (or permit any Affiliate, officer, director, manager, employee, attorney, accountant, consultant, financial
    advisor or other agent of Intercure or any Intercure Subsidiary to take or omit to take any action) that would, or could reasonably
    be expected to, (A) result in any of Intercure’s representations and warranties set forth in this Agreement or any certificate
    delivered in connection with the Business Combination being or becoming untrue, or (B) result in a failure to satisfy any of the
    conditions set forth in Article 6;

 

    	-45-

     

    

 

	5.7	Support
    of Business Combination

 

	 	(a)	Each
    Party covenants and agrees that it shall:

 

	 	(i)	take
    all reasonable actions to consummate the Business Combination and the transactions contemplated thereunder, subject only to the terms
    and conditions hereof and to not take any action contrary to or in opposition to the Business Combination, except as required by
    statutory law, and in the case of Intercure, use its commercially reasonable efforts to cause its shareholders to vote their respective
    shares in favour of the Business Combination and all of the matters contemplated thereunder,
	 	 	 
	 	(ii)	use
    all commercially reasonable efforts to obtain all appropriate Regulatory Approvals;
	 	 	 
	 	(iii)	not,
    other than in connection with the Business Combination, reorganize, amalgamate or merge with any other person, nor acquire by amalgamating,
    merging or consolidating with, purchasing a majority of the voting securities or substantially all of the assets of or otherwise,
    any business or Person which acquisition or other transaction would reasonably be expected to prevent or materially delay the Business
    Combination contemplated hereby; and
	 	 	 
	 	(iv)	co-operate
    fully with the other Parties and to use all commercially reasonable efforts to otherwise complete the Business Combination, unless
    such cooperation and efforts would subject such Party to liability or would be in breach of applicable Laws.

 

	5.8	Other
    Filings

 

The
Parties shall, as promptly as practicable hereafter, prepare and file all filings required under any Securities Laws or any other applicable
Laws relating to the Business Combination contemplated hereby.

 

	5.9	Additional
    Agreements

 

Subject
to the terms and conditions of this Agreement and subject to fiduciary obligations under applicable Laws, each of the Parties hereto
agrees to use all commercially reasonable efforts to take, or cause to be taken, all action and to do, or cause to be done, all things
necessary, proper or advisable to consummate and make effective as promptly as practicable the Business Combination contemplated by this
Agreement and to cooperate with each other in connection with the foregoing, including using commercially reasonable efforts:

 

	 	(a)	to
    obtain all necessary waivers, consents and approvals from other Parties to material agreements, leases and other contracts or agreements;

 

    	-46-

     

    

 

	 	(b)	to
    defend all lawsuits or other legal proceedings challenging this Agreement or the consummation of the Business Combination contemplated
    hereby;
	 	 	 
	 	(c)	to
    cause to be lifted or rescinded any injunction or restraining order or other order adversely affecting the ability of the Parties
    to consummate the Business Combination contemplated hereby;
	 	 	 
	 	(d)	to
    effect all necessary registrations and other filings and submissions of information requested by the ISA, TASE, NEO, TSX and Nasdaq;
	 	 	 
	 	(e)	to
    effect all necessary registrations and other filings and submissions of information requested by Government Authorities; and
	 	 	 
	 	(f)	to
    fulfill all conditions and satisfy all provisions of this Agreement.

 

For
purposes of the foregoing, the obligation to use “commercially reasonable efforts” to obtain waivers, consents and
approvals to loan agreements, leases and other contracts shall not include any obligation to agree to a materially adverse modification
of the terms of such documents or to prepay or incur additional material obligations to such other Parties.

 

5.10       Waiver
of Access to Escrow Account. Notwithstanding anything to the contrary in this Agreement, Intercure hereby irrevocably waives and
releases, and shall cause any Affiliate of Intercure in connection with the Business Combination, to waive and release, on substantially
similar terms, any and all right, title, interest, causes of action and claims of any kind, whether in tort or contract or otherwise
(each, a “Claim”), in or to, and any and all right to seek payment of any amounts due to it in connection with the
Business Combination or this Agreement, out of the Escrow Account, or from monies or other assets released from the Escrow Account that
are payable to holders of Subversive Restricted Voting Units or its underwriters, and hereby irrevocably waives and releases any Claim
it may have in the future, as a result of, or arising out of, this Agreement or the Business Combination, which Claim would reduce or
encumber any monies or other assets released from the Escrow Account that are payable to holders of Subversive Restricted Voting Units
or its underwriters, or to any monies or other assets in the Escrow Account, and further agrees not to seek recourse, reimbursement,
payment or satisfaction of any Claim against the Escrow Account, any monies or other assets released from the Escrow Account that are
payable to holders of Subversive Restricted Voting Units or its underwriters or any monies or other assets in the Escrow Account for
any reason whatsoever or to bring any proceedings against the Escrow Account or the Escrow Agent.

 

	 	5.11	Access.

 

(a)       Except
to the extent prohibited by applicable Law, Intercure shall, and shall cause each Intercure Subsidiary to, (i) afford to Subversive and
its representatives, reasonable access, during normal business hours and upon reasonable prior notice to Intercure, to all of the assets,
properties, personnel, contracts, books and records of Intercure as Subversive may from time to time reasonably request, and (ii) furnish
Subversive with such information relating to Intercure and the Intercure Subsidiaries as Subversive may from time to time reasonably
deem necessary and advisable, provided that, with respect to clause (i), any such access shall be conducted in such a manner as not to
interfere unreasonably with the operations of Intercure or the Intercure Subsidiaries.

 

    	-47-

     

    

 

(b)       Except
to the extent prohibited by applicable Law, Subversive shall, and shall cause each Subversive Subsidiary to, (i) afford to Intercure
and its representatives, reasonable access, during normal business hours and upon reasonable prior notice to Intercure, to all of the
assets, properties, personnel, contracts, books and records of Subversive as Intercure may from time to time reasonably request, and
(ii) furnish Intercure with such information relating to Subversive and the Subversive Subsidiaries as Intercure may from time to time
reasonably deem necessary and advisable, provided that, with respect to clause (i), any such access shall be conducted in such a manner
as not to interfere unreasonably with the operations of Subversive or the Subversive Subsidiaries.

 

(c)       Upon
Subversive’s request, Subversive and its representative shall be provided with reasonable access to suppliers and distributors
of Intercure and the Intercure Subsidiaries, provided that such access shall require the prior written consent of Intercure (not
to be unreasonably withheld, conditioned or delayed) and a representative of Intercure shall be entitled to participate in any discussions.

 

(d)       Intercure
shall report to Subversive, as and when reasonably requested, concerning the status of the operations, finances and affairs of the Intercure
and its Subsidiaries and deliver to Subversive periodic financial reports in the form that it customarily prepares for its internal purposes.

 

ARTICLE
6

CONDITIONS AND CLOSING MATTERS

 

	6.1	Mutual
                                            Conditions Precedent

 

The
respective obligations of the Parties hereto to complete the Arrangement pursuant to the Plan of Arrangement shall be subject to the
satisfaction, on or before the Effective Date, of the following conditions precedent, each of which may be waived only by the mutual
consent of the Parties:

 

	 	(a)	the
    requisite shareholder approvals of Intercure at the Intercure Meeting shall have been obtained;
	 	 	 
	 	(b)	the
    Intercure Share Consolidation shall have occurred;
	 	 	 
	 	(c)	the
    conditional approval of the NEO shall have been obtained by Subversive to enable the Business Combination to qualify as Subversive’s
    Qualifying Transaction;
	 	 	 
	 	(d)	a
    final receipt for the Prospectus shall have been issued by or on behalf of the Subversive Securities Authorities;
	 	 	 
	 	(e)	the
    Interim Order and the Final Order shall have each been obtained on terms consistent with this Agreement;
	 	 	 
	 	(f)	the
    U.S. Registration Statement shall have become effective under the Securities Exchange Act and the Intercure Shares shall have been
    approved for listing on the Nasdaq;

 

    	-48-

     

    

 

	 	(g)	approval
    for listing and trading of Subversive Limited Partnership Units on the TSX shall have been obtained;
	 	 	 
	 	(h)	Intercure
    Shares shall have been approved for, and begun trading on, the TSX so as to enable the “dual listing” regime to apply
    to the Intercure Shares;
	 	 	 
	 	(i)	ISA
    and TASE approval for listing and trading of Intercure Shares on the TSX and the TASE under the “dual listing” regime
    shall have been obtained;
	 	 	 
	 	(j)	there
    shall have been no action taken under any applicable Law or by any Governmental Authority and there shall not be in force any order
    or decree restraining or enjoining the consummation of the Business Combination;
	 	 	 
	 	(k)	all
    corporate and Regulatory Approvals shall have been obtained; and
	 	 	 
	 	(l)	this
    Agreement shall not have been terminated pursuant to Article 7.

 

If
any of the above conditions shall not have been complied with or waived by the Parties on or before the Completion Deadline or, if earlier,
the date required for the performance thereof, then a Party may terminate this Agreement in circumstances where the failure to satisfy
any such condition is not the result, directly or indirectly, of a breach of this Agreement by the Party terminating the Agreement. In
the event that the failure to satisfy any one or more of the above conditions precedent results from a material default by a Party of
its obligations under this Agreement and if such condition(s) precedent would have been satisfied but for such default, such defaulting
Party shall not rely on such failure (to satisfy one or more of the above conditions) as a basis for its own non-compliance with its
obligations under this Agreement.

 

	6.2	Additional
                                            Conditions Precedent to the Obligations of Intercure

 

The
obligations of Intercure to complete the Arrangement shall also be subject to the satisfaction, on or before the Effective Date, of each
of the following conditions precedent (each of which is for the exclusive benefit of Intercure and may be waived by Intercure and any
one or more of which, if not satisfied or waived, will relieve Intercure of any obligation under this Agreement):

 

	 	(a)	Neither
    Subversive nor the General Partner shall have breached, or failed to comply with, in any material respect, any of its covenants or
    other obligations under this Agreement;
	 	 	 
	 	(b)	the
    representations and warranties of Subversive and the General Partner (other than the Subversive Fundamental Representations) contained
    in this Agreement (without giving effect to any “materiality” or “Material Adverse Effect” qualifiers) shall
    be true and correct in all respects as of the Effective Date with the same effect as if made as of the Effective Date (other than
    such representations and warranties that are made as of a specified date, which representations and warranties shall be true and
    correct as of such specified date), except where the failure of any such representations and warranties to be so true and correct
    has not had a Material Adverse Effect. The Subversive Fundamental Representations shall be true and correct in all material respects
    as of the Effective Date with the same effect as if made as of the Effective Date (other than such representations and warranties
    that are made as of a specified date, which representations and warranties shall be true and correct as of such specified date);

 

    	-49-

     

    

 

	 	(c)	the
    Financing shall have raised at least $25 million in gross proceeds at a price per unit not less than $10 per unit to Subversive;
    
	 	 	 
	 	(d)	Immediately
    prior to the Effective Date, (i) the total available cash in the Escrow Account net of anticipated payments in respect of redemption
    plus (ii) amounts funded or committed pursuant to the Financing, shall be at least $55,000,000 (the “Minimum Cash Amount”).
    Such Minimum Cash Amount shall be unrestricted (subject to completion of a Qualifying Transaction) and Subversive (and the Subversive
    Subsidiaries) shall not have incurred any liabilities or obligations that are payable in cash in connection with the Business Combination
    (including all transaction costs of Subversive, and all reasonable legal and accounting fees of Intercure) in excess of $15,000,000
    (plus the amount of any credit to the fees of the TSX Listing obtained by Subversive for the benefit of Intercure); and
	 	 	 
	 	(e)	The
    Boards of Directors of the General Partner and the officers and Governing Documents of Subversive and the General Partner shall have
    been replaced and/or amended, as applicable, as requested by Intercure.

 

If
any of the above conditions shall not have been complied with or waived by Intercure on or before the Completion Deadline or, if earlier,
the date required for the performance thereof, then Intercure may terminate this Agreement in circumstances where the failure to satisfy
any such condition is not the result, directly or indirectly, of a breach of this Agreement by Intercure. In the event that the failure
to satisfy any one or more of the above conditions precedent results from a material default by Intercure of its obligations under this
Agreement and if such condition(s) precedent would have been satisfied but for such default, Intercure shall not rely on such failure
(to satisfy one or more of the above conditions) as a basis for its own noncompliance with its obligations under this Agreement.

 

	6.3	Additional
                                            Conditions Precedent to the Obligations of Subversive

 

The
obligations of Subversive to complete the Arrangement shall also be subject to the satisfaction, on or before the Effective Date, of
each of the following conditions precedent (each of which is for the exclusive benefit of Subversive and may be waived by Subversive
and any one or more of which, if not satisfied or waived, will relieve Subversive of any obligation under this Agreement):

 

	 	(a)	no
    Material Adverse Effect with respect to Intercure or the Intercure Subsidiaries taken as a whole shall have occurred between September
    30, 2020 and the Effective Date;
	 	 	 
	 	(b)	Intercure
    shall not have breached, or failed to comply with, in any material respect, any of its covenants or other obligations under this
    Agreement;
	 	 	 
	 	(c)	Intercure
    shall have obtained all third party consents and authorizations required to be obtained as set forth in the Intercure Disclosure
    Schedules in response to Section 4.1(i)(c);

 

    	-50-

     

    

 

	 	(d)	the
    representations and warranties of Intercure (other than the Intercure Fundamental Representations) contained in this Agreement (without
    giving effect to any “materiality” or “Material Adverse Effect” qualifiers) shall be true and correct in
    all respects as of the Effective Date with the same effect as if made as of the Effective Date (other than such representations and
    warranties that are made as of a specified date, which representations and warranties shall be true and correct as of such specified
    date), except where the failure of any such representations and warranties to be so true and correct has not had a Material Adverse
    Effect. The Intercure Fundamental Representations shall be true and correct in all material respects as of the Effective Date with
    the same effect as if made as of the Effective Date (other than such representations and warranties that are made as of a specified
    date, which representations and warranties shall be true and correct as of such specified date);
	 	 	 
	 	(e)	Subversive,
    Intercure and the Representative shall have entered into the Indemnification Agreement;
	 	 	 
	 	(f)	Subversive
    shall have received Support and Lock-Up Agreements duly executed by all Intercure directors and officers;
	 	 	 
	 	(g)	All
    Intercure Shares required to be issued pursuant to and in accordance with this Agreement and the Plan of Arrangement shall have been
    validly and irrevocably issued, not subject to withholding of any kind, shall be fully paid and non-assessable, and shall not be
    subject to any restrictions under Israeli Law that prevent such Intercure Shares from being freely tradeable on TASE or TSX or becoming
    freely tradeable on Nasdaq; and
	 	 	 
	 	(h)	The
    Director Appointment shall have occurred and the Boards of Directors and officers of Intercure shall be as set forth in Section
    2.3.

 

If
any of the above conditions shall not have been complied with or waived by Subversive on or before the Completion Deadline or, if earlier,
the date required for the performance thereof, then Subversive may terminate this Agreement in circumstances where the failure to satisfy
any such condition is not the result, directly or indirectly, of a breach of this Agreement by Subversive. In the event that the failure
to satisfy any one or more of the above conditions precedent results from a material default by Subversive of its obligations under this
Agreement and if such condition(s) precedent would have been satisfied but for such default, Subversive shall not rely on such failure
(to satisfy one or more of the above conditions) as a basis for its own noncompliance with its obligations under this Agreement.

 

	6.4	Closing
    Matters

 

The
completion of the transactions contemplated under this Agreement shall be effected via electronic exchange on the Effective Date.

 

    	-51-

     

    

 

ARTICLE
7

TERMINATION AND AMENDMENT

 

	7.1	Termination

 

This
Agreement may be terminated by written notice promptly given to the other Party hereto, at any time prior to the Effective Date:

 

	 	(a)	by
    mutual agreement in writing by the Parties;
	 	 	 
	 	(b)	by
    either Subversive or Intercure if the Business Combination has not occurred on or prior to the Completion Deadline (provided that
    the failure of the Business Combination to occur by the Completion Deadline has not been caused by a breach of this Agreement or
    any other Document by the Party exercising the right to terminate this Agreement); and
	 	 	 
	 	(c)	as
    set forth in Sections 6.1, 6.2 and 6.3 of this Agreement.

 

	7.2	Effect
    of Termination

 

In
the event of the termination of this Agreement as provided in Section 7.1 hereof, this Agreement shall forthwith have no further
force or effect and there shall be no obligation on the part of Subversive or Intercure hereunder except as set forth in Section 7.3
hereof and this Section 7.2, which provisions shall survive the termination of this Agreement. Nothing herein shall relieve
any Party from liability for any breach of this Agreement.

 

	7.3	Expenses

  

Each
Party shall pay its own costs and expenses (including all legal, accounting and financial advisory fees and expenses) incurred in connection
with the completion of the Business Combination, including without limitation, expenses related to the preparation, execution and delivery
of all agreements including, without limitation, this Agreement and other documents referenced herein, and for greater certainty, Subversive
shall be responsible for paying all costs and fees payable to the NEO in connection with its review of the Business Combination, all
listing fees incurred or to be incurred in connection with the completion of the Business Combination and all costs and fees associated
with the preparation and filing of the Prospectus or information circular, as may be required by the NEO, and Intercure shall be responsible
for paying all costs and fees payable in connection with the filing of the U.S. Registration Statement and the U.S. Resale Registration
Statement, and all fees and expenses of the Nasdaq Listing and the TSX Listing (provided no commitment to pay the listing fee for the
TSX shall occur prior to certainty of consummation of the transactions).

 

	7.4	Amendment

 

This
Agreement may, at any time on or before the Effective Date be amended by mutual agreement between the Parties. This Agreement may not
be amended except by an instrument in writing signed by the appropriate officers on behalf of each of the Parties hereto.

 

	7.5	Waiver

 

A
Party may (i) extend the time for the performance of any of the obligations or other acts of the other Party, (ii) waive compliance with
any of the other Party’s agreements or the fulfillment of any of its conditions contained herein or (iii) waive inaccuracies in
another Party’s representations or warranties contained herein or in any document delivered by the other Party hereto; provided,
however, that any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of such Party.

 

    	-52-

     

    

 

ARTICLE
8

GENERAL

 

	8.1	Notices

 

All
notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given or made
as of the date delivered or sent if delivered personally or sent by e-mail or sent by prepaid overnight courier to the Parties at the
following addresses (or at such other addresses as shall be specified by the Parties by like notice):

 

	 	if
    to Intercure, to:	 
	 	 	 
	 	Intercure
    Ltd.	 
	 	85
    Medinat Hayehudim Boulevard	 
	 	Herzeliya
    Pituach	 
	 	Israel	 
	 	Attention:	Alex
    Rabinovitch, CEO	 
	 	E-mail:	alex@canndoc-pharma.com
    	 
	 	 	 	 
	 	with
    a copy (which shall not constitute notice) to:	 
	 	 	 
	 	Doron
    Tikotzky Kantor Gutman Nass & Amit Gross	 
	 	BSR
    4, 33rd Floor	 
	 	7
    Metsada Street	 
	 	Bnei
    Brak	 
	 	Israel	 
	 	Attention:	Ronen
    Kantor, Adv.	 
	 	E-mail:	rkantor@dtkgg.com
    	 
	 	 	 	 
	 	if
    to Subversive, to:	 
	 	 	 
	 	Subversive
    Real Estate Acquisition REIT LP/	 
	 	Subversive
    Real Estate Sponsor LLC	 
	 	135
    Grand Street, 2nd Floor	 
	 	New
    York, NY 10013	 
	 	Attention:
    Leland Hensch	 	 
	 	Email: 	leland@subversivecapital.com	 
	 	 	 	 
	 	with
    a copy (which shall not constitute notice) to:	 
	 	 	 
	 	Paul
    Hastings LLP	 
	 	200
    Park Avenue	 
	 	New
    York, NY 10166	 
	 	Attention:
    Barry A. Brooks	 
	 	Email: 	barrybrooks@paulhastings.com	 
	 	 	 	 
	 	Goodmans
    LLP	 
	 	333
    Bay St., Suite 3400	 
	 	Toronto,
    ON M5H 2S7	 
	 	Attention:
    Stephen Pincus	 	 
	 	Email: 	spincus@goodmans.ca	 

 

    	-53-

     

    

 

	8.2	Assignment

 

Except
as expressly permitted by the terms hereof, neither this Agreement nor any of the rights, interests or obligations hereunder shall be
assigned by either of the Parties hereto without the prior written consent of the other Party which shall not be unreasonably withheld.

 

	8.3	Complete
    Agreement

 

This
Agreement sets forth the entire understanding between the Parties hereto and supersedes all prior agreements, arrangements and communications,
whether oral or written, with respect to the subject matter hereof. No other agreements, representations, warranties or other matters,
whether oral or written, shall be deemed to bind the Parties hereto with respect to the subject matter hereof.

 

	8.4	Further
    Assurances

 

Each
Party hereto shall, from time to time, and at all times hereafter, at the request of the other Party hereto, but without further consideration,
do all such further acts and execute and deliver all such further documents and instruments as shall be reasonably required in order
to fully perform and carry out the terms and intent hereof.

 

	8.5	Severability

 

Whenever
possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable Law. Any
provision of this Agreement that is invalid or unenforceable in any jurisdiction shall be ineffective to the extent of such invalidity
or unenforceability without invalidating or rendering unenforceable the remaining provisions hereof, and any such invalidity or unenforceability
in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

	8.6	Counterpart
    Execution

 

This
Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together shall
constitute one and the same instrument.

 

	8.7	Investigation
    by Parties

 

No
investigations made by or on behalf of either Party or any of their respective authorized agents at any time shall have the effect of
waiving, diminishing the scope of or otherwise affecting any representation, warranty or covenant made by the other Party in or pursuant
to this Agreement.

 

	8.8	Public
    Announcement; Disclosure and Confidentiality

 

	 	(a)	Unless
    and until the transactions contemplated in this Agreement will have been completed, none of the Parties shall make any public announcement
    concerning this Agreement or the matters contemplated herein, their discussions or any other memoranda, letters or agreements between
    them relating to the matters contemplated herein without the prior consent of the other Parties, provided that no party shall be
    prevented from making any disclosure which is required to be made by law or any rules of a stock exchange or similar organization
    to which it is bound. In the event a Party is required to disclose information related to the transactions contemplated in this Agreement
    pursuant to applicable Law, regulation or the rules of a stock exchange or similar organization, such Party will be responsible for
    the accuracy of such disclosure and that it contains no misrepresentations and constitutes a true and plain disclosure of all material
    facts. For the avoidance of doubt, Subversive will not be responsible for any information included in any disclosure made by Intercure.

 

    	-54-

     

    

 

	 	(b)	All
    information provided to or received by the parties hereunder shall be treated as confidential (“Confidential Information”).
    Without limiting the foregoing, the Parties acknowledge that Intercure’s shares are listed on the TASE, and Subversive’s
    shares are traded on the NEO, and each Party’s Confidential Information may be considered “inside information”
    pursuant to Israeli securities laws and regulations, and/or material non-public information in accordance with applicable Canadian
    and United States securities laws. Subject to the provisions of this Section, no Confidential Information shall be published by any
    party hereto without the prior written consent of the others. The consent required by this Section shall not apply to a disclosure
    to: (a) comply with any applicable laws, stock exchange rules or a regulatory authority having jurisdiction; (b) a director, officer
    or employee of a party; (c) an Affiliate of a party; (d) a consultant, contractor or subcontractor of a party that has a bona fide
    need to be informed; or (e) any third party to whom the disclosing party has assigned (in compliance with the terms of this Agreement)
    any of its rights under this Agreement; provided, however, that in the case of subsection (a), such disclosing Party shall give the
    other Parties a reasonable opportunity to review and comment on such disclosure and will consider such comments in good faith, and
    in the case of subsection (e) the third party or parties, as the case may be, agree to maintain in confidence any of the Confidential
    Information so disclosed to them.
	 	 	 
	 	(c)	The
    obligations of confidence and prohibitions against use of Confidential Information under this Agreement shall not apply to information
    that the disclosing party can show by reasonable documentary evidence or otherwise: (a) as of the date of this Agreement, was in
    the public domain; (b) after the date of this Agreement, was published or otherwise became part of the public domain through no fault
    of the disclosing party or an Affiliate thereof (but only after, and only to the extent that, it is published or otherwise becomes
    part of the public domain); or (c) was information that the disclosing party or its Affiliates were required to disclose pursuant
    to the order of any Government Authority or judicial authority.

 

	8.9	Representative.

 

	 	(a)	By
    executing and delivering a Letter of Transmittal or by virtue of consummation of the Plan of Arrangement, each Subversive Limited
    Partner hereby irrevocably constitutes and appoints Subversive Real Estate Sponsor LLC as its true and lawful attorney-in-fact and
    agent (the “Representative”) with full power of substitution to do any and all things and execute any and
    all documents which may be necessary, convenient or appropriate to facilitate the consummation of the transactions contemplated hereby
    and the exercise of all rights and the performance of all obligations hereunder, including: (i) receiving payments under or pursuant
    to this Agreement and disbursements thereof to the Subversive Limited Partner, as contemplated by this Agreement; (ii) receiving
    and forwarding of notices and communications pursuant to this Agreement and accepting service of process; (iii) giving or agreeing
    to, on behalf of all the Subversive Limited Partner, any and all consents, waivers and amendments deemed by the Representative, in
    its reasonable and good faith discretion, to be necessary or appropriate under this Agreement and the execution or delivery of any
    documents that may be necessary or appropriate in connection therewith; and (iv) with respect to any and all matters arising under
    this Agreement, (A) disputing or refraining from disputing, on behalf of each Subversive Limited Partner relative to any amounts
    to be received by the Subversive Limited Partner under this Agreement or any agreements contemplated hereby, or any claim made by
    Subversive under this Agreement, (B) negotiating and compromising, on behalf of each Subversive Limited Partner, any dispute that
    may arise under, and exercise or refrain from exercising any remedies available under, this Agreement, and (C) executing, on behalf
    of each Subversive Limited Partner, any settlement agreement, release or other document with respect to such dispute or remedy, except
    in each case with respect to a dispute between any Subversive Limited Partner on the one hand and the Representative on the other
    hand; provided, however, that, in each case, the Representative shall not take any action adverse to any Subversive Limited Partner
    unless such action is also taken proportionately with respect to the others.

 

    	-55-

     

    

 

	 	(b)	Each
    Subversive Limited Partner hereby agrees that: (i) in all matters in which action by the Representative is required or permitted,
    the Representative is authorized to act on behalf of such Subversive Limited Partner; (ii) all decisions, actions, consents and instructions
    by the Representative shall be binding upon all of the Subversive Limited Partners, and no Subversive Limited Partner shall have
    the right to object to, dissent from, protest or otherwise contest any such decision, action, consent or instruction; and (iii) the
    appointment of the Representative is coupled with an interest and shall be irrevocable by such Subversive Limited Partner in any
    manner or for any reason.
	 	 	 
	 	(c)	The
    Representative is hereby authorized to establish an expense fund (the “Expense Fund”), which shall be funded by
    Subversive at or prior to the consummation of the Arrangement in an amount of $50,000. The Representative may use the Expense Fund
    to pay or be reimbursed for any fees, costs, expenses or other obligations incurred by the Representative acting in its capacity
    as such. The Subversive Limited Partners will not receive any interest or earnings on the Expense Fund and irrevocably transfer and
    assign to the Representative any ownership right that they may otherwise have had in any such interest or earnings. The Representative
    will not be liable for any loss of principal of the Expense Fund other than as a result of its gross negligence or willful misconduct.
    For tax purposes, the Expense Fund shall be treated as having been received and voluntarily set aside by the Subversive Limited Partners
    at the time of Closing. The Parties agree that the Representative is not acting as a withholding agent or in any similar capacity
    in connection with the Expense Fund. The Representative shall be indemnified and held harmless by the Subversive Limited Partners
    out of the Expense Fund from and against any and all costs, expenses (including the fees and expenses of its counsel), losses or
    liabilities incurred by the Representative arising out of or in connection with the Representative’s execution and performance
    of this Agreement. The Expense Fund shall be retained in whole or in part by the Representative for such time as the Representative
    shall determine in its sole discretion. If the Representative shall determine in its sole discretion to return all or any portion
    of the Expense Fund, such amount shall be released to Intercure. In no event will the Representative be required to advance its own
    funds on behalf of the Subversive Limited Partners or otherwise. The foregoing indemnities will survive the consummation of the Arrangement,
    the resignation or removal of the Representative or the termination of this Agreement.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]

 

    	-56-

     

    

 

IN
WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date first written above by their respective officers
thereunto duly authorized.

 

	 	INTERCURE
    LTD.
	 	 
	 	Per:	 
	 	 	 
	 	CANNDOC
    ACQUISITION SUBCO LTD.
	 	 
	 	Per:	 
	 	 	 
	 	SUBVERSIVE
    REAL ESTATE ACQUISITION REIT LP
	 	 
	 	Per:	 
	 	 	 
	 	SUBVERSIVE
    REAL ESTATE ACQUISITION REIT (GP) INC.
	 	 
	 	Per:	 
	 	 	 
	 	SUBVERSIVE
    REAL ESTATE SPONSOR LLC
	 	 
	 	Per:	 

 

    	-57-

     

    

 

Schedule
A

PLAN OF ARRANGEMENT

(see
attached)

 

    	A-1Exhibit
4.2

 

Partnership
Agreement

 

Made
and signed in Beit Ha’Emek on 21st of the month of May 2015

 

	Between:	Canndoc
    Ltd.
	 	Private
    company limited in shares
	 	Pcn
    51441851
	 	Pob
    4367 (Geula branch) Tel Aviv - Yafo
	 	By
    managers and authorized signatories: Yaron Blovstein and Avner Barak
	 	(hereinafter:
    “Canndoc”)

 

Of
the One Part

 

	And
    Between:	Beit
    Ha’Emek Agriculture - Cooperative Agricultural Association Ltd.
	 	Number
    57-003823-2
	 	(hereinafter:
    “Beit Ha’Emek Agriculture”)
	 	Address,
    Kibbutz Beit Ha’Emek, Mobile Post Oshrat ___
	 	 
	 	Kibbutz
    Beit Ha’Emek Cooperative Agricultural Association Ltd.
	 	Number
    570007609
	 	(hereinafter:
    “the Kibbutz”)

 

Of
the Second Part

 

	 	A
    new Association which shall be established by the Beit Ha’Emek corporations
	 	(hereinafter:
    “the Association”)

 

Whereas
the Kibbutz is the holder of the lease rights in agricultural land designated for agricultural cultivation in an area of 5 Dunam
located in plot 18480, parcel 17, and whose details and full description, including its boundaries, appear in the Diagram attached hereto
as Appendix A (“Diagram”), and which are marked in a red line in the Diagram (hereinafter: “the
Property”).

 

    	 

     

    

 

And
whereas, the Kibbutz has granted a right of use in the Property to Beit Ha’Emek Agriculture, which is wholly controlled by
the Kibbutz.

 

And
whereas, the Kibbutz is a party to this agreement due to its being the holder of the rights in the Property and being the owner of
the water rights and since for purposes of approval and granting of validity to this agreement, the approval of the competent institutions
is required for the engagement in this agreement.

 

And
whereas, the Kibbutz has founded a new association (“the Association”) for purposes of its engagement in this contract
and in unregistered partnership with Canndoc.

 

And
whereas, the Kibbutz and Beit Ha’Emek Agriculture issue their agreement for the Association and Canndoc to make use of the
Property in accordance with and subject to the provisions of this agreement.

 

And
whereas, Canndoc hereby declares that it has all of the approvals, permits and consent required by any relevant authority, including
the Ministry of Health and the Ministry of Internal Defense, including the Israel Police.

 

And
whereas, the Association and Canndoc wish to operate in an unregistered partnership in the framework of a joint venture which shall
operate in the property, a farm for both cultivation of cannabis plants for medical use and extraction of medical cannabis oil
(hereinafter: “the Farm” and “the Partnership”) for marketing by the company Canndoc Ltd., at its
exclusive discretion (hereinafter: “Canndoc”) and in accordance with the terms of the growers license which Canndoc
holds, in accordance with and subject to the provisions of this agreement below. A copy of the growers license of Canndoc is attached
hereto as Appendix A-1.

 

And
whereas, the Partnership is for cultivation purposes only (as defined in this agreement), and the Association and/or the Kibbutz
shall not have any right in any venture and/or collaboration and/or other activity with Canndoc unless agreed otherwise in advance and
in writing. However, on the other hand, it is clarified and declared hereby that the Association and/or the Kibbutz and/or any party
on their behalf does not have and shall not have any liability towards the final product and/or in respect of the use thereof and/or
in respect of the results of the use thereof, and all as specified below in this agreement.

 

    	 

     

    

 

And
whereas the Partnership will operate in the framework of an unregistered partnership.

 

Accordingly
it is agreed between the parties as follows:

 

 Preamble

 

	1.	The
    preamble and the appendices to this agreement constitute an inseparable part thereof.
	 	 
	2.	The
    headings of the clauses in this agreement were intended for convenience of reference only, and may not be accorded any interpretive
    significance.
	 	 
	 	In
    this agreement the following terms shall have the meaning appearing adjacent thereto:
	 	 
	 	The
    Areas of the Property - an area of approximately 5 Dunam (with agricultural greenhouses) and which is marked in the Diagram
    attached as Appendix A.
	 	 
	 	(The
    Kibbutz will maintain a reserve of agricultural land available, adjacent to the Property, for purposes of future expansion of the
    activity of the Partnership in an area of 3 Dunam).
	 	 
	3.	This
    agreement exhausts all of the agreements of the parties related to the Property, the Partnership and its activity. Upon the signature
    of this agreement, all of the declarations of the parties and/or their undertakings and/or any representation and/or agreement, whether
    orally or in writing, made by them prior to the signature upon this agreement, concerning the Property and/or the Partnership and/or
    its activity, are null and void.
	 	 
	4.	Every
    party to this agreement undertakes to bring this agreement for approval of its competent institutions within 40 days from the date
    on which the last of the parties has signed upon the agreement. Approval of the competent institutions is a suspending condition
    to the entry into force of this agreement. Approval of the competent institutions will be attached as Appendices B and C
    respectively, to such extent as they are issued and after they are issued.

 

    	 

     

    

 

The
Cultivation

 

	5.	The
    joint activity of the partners will involve cultivation of medical cannabis plants and/or extraction of oil from medical cannabis
    (hereinafter: “the Cultivation”) in the Property.
	 	 
	6.	For
    purposes of this agreement, “Cultivation” means, inter alia: treatment of the ground, irrigation,
    growing, handling of the Cultivation, harvesting and every agronomic activity required for the Cultivation in the area of the Cultivation
    - as shall be agreed between the parties, preparation of seedlings, and extraction of oils from the medical cannabis. Save
    for improvement and/or cultivation of strains, research and so forth.
	 	 
	 	It
    is emphasized that the Partnership will engage solely and exclusively in Cultivation as defined in this agreement. All of the operation
    and all of the responsibility for the actions carried out prior to Cultivation and/or thereafter, such as: development of strains
    and activities which shall be carried out at the end of the Cultivation, conversion of the oil and/or medical cannabis into other
    products, marketing to patients, product liability from the moment of delivery to Canndoc and so forth, shall not apply to the Partnership
    and/or the Association and/or the Kibbutz and/or any party on their behalf. The Partnership between the parties is for purposes of
    Cultivation only.
	 	 
	 	It
    is clarified that to such extent as the product which shall be received shall be of an inferior quality, as defined below, Canndoc
    shall not be obligated to purchase the product of the Partnership. “Inferior quality” in this matter - in accordance
    with the definitions of the Ministry of Health, defined below. The Partnership shall have a right to produce an alternative product
    in these circumstances and Canndoc shall acquire it in accordance with its needs.

 

    	 

     

    

 

The
Partnership and its purpose

 

	7.	The
    partners - the Association and Canndoc will operate in the framework of an unregistered partnership.
	 	 
	8.	The
    principal purpose of the Partnership shall be a joint venture for Cultivation of medical cannabis plants in Beit Ha’Emek .
	 	 
	9.	The
    rights of the parties in the Partnership shall be: 70% Canndoc and 30% the Association.
	 	 
	10.	The
    Partnership will engage in everything required and shall be responsible for Cultivation of cannabis plants and production of oils
    and their sale to Canndoc Ltd., maintenance and current and proper operation of the Farm in accordance with the requirements of the
    regulator.
	 	 
	11.	The
    parties undertake to act jointly for the approval of this agreement and of the Partnership by the competent Authority pursuant to
    the Agricultural Settlement Law and to sign upon any document and to carry out any action which shall be required for the approval
    and operation of the Partnership. Such approval constitutes a suspending condition to the validity of this agreement as specified
    below.
	 	 
	12.	The
    Partnership will operate, to such extent as possible, in accordance with the Cultivation plan which was prepared by the parties for
    the joint operation, which is attached as Appendix D of this agreement.
	 	 
	13.	It
    is clarified that the Partnership shall not bear any direct or indirect liability for the products of Canndoc which are marketed
    to the patients and/or any other entity, or any other liability for matters which are not related to the process of Cultivation.
    The exclusive liability for this matter shall be of Canndoc and it shall indemnify the Association and/or Beit Ha’Emek in the
    event that a lawsuit and/or a demand shall be submitted against them in respect of the products of Canndoc Ltd., and a judgement
    shall be issued, subject to that stated in this agreement. In addition, the Partnership will finance the cost of product liability
    insurance with an insurer, and it undertakes to indemnify the parties to this agreement in the event that a lawsuit and/or a demand
    shall be submitted against them in respect of the product. The Kibbutz may insure itself in additional insurance as against any damage
    which shall be caused to patients in respect of the product in a separate insurance policy, and in such instance the Kibbutz will
    bear the costs of the additional insurance itself. For the sake of removal of doubt it is clarified that this agreement does not
    grant Canndoc and/or the Partnership, in any manner or form, rights in the land of Kibbutz Beit Ha’Emek and/or the water rights
    of Kibbutz Beit Ha’Emek and/or in any other of the assets of Kibbutz Beit Ha’Emek , other than the rights of use in the
    Property specified in this agreement which shall be accorded to the Partnership, and for the period of this agreement alone. It is
    further clarified that this agreement does not grant the Kibbutz and/or the Association any right whatsoever in the strains, the
    Cultivation protocols, the growers license, the know-how, the list of patients and the business connections belonging to Canndoc
    Ltd.

 

    	 

     

    

 

Management
of the Partnership

 

	14.	The
    accounting of the Partnership will be carried out on the books of Canndoc with a pricing separation. The accounting of Canndoc (including
    the payroll accounting) will be managed in entirety at the accounting department of Beit Ha’Emek at Beit Ha’Emek in accordance
    with the prices and conditions concluded in accordance with the market prices. Beit Ha’Emek will be responsible for placing
    a workstation at the offices of the company which is connected to an ERP (One) program, and will enable control and supervision at
    all times.
	 	 
	15.	The
    management of the Partnership will be composed of three representatives of Canndoc and two representatives of the Association. Each
    party will appoint the representatives by notice in writing to the counterparty and shall be entitled to replace the representatives
    from time to time, by notice of writing. This clause will not change without the agreement of the parties in writing.
	 	 
	16.	The
    management of the Partnership will approve the annual Cultivation plan and any deviation therefrom, and shall be authorized to pass
    any resolution in the framework of the purposes of the Partnership.

 

    	 

     

    

 

	17.	Resolutions
    in the management of the Partnership will be passed by a majority, save for the matters specified below, with respect to which a
    unanimous decision is required:

 

	 	17.1.	Sale
    of the rights in the holding in the Partnership or part thereof.
	 	 	 
	 	17.2.	The
    entry of additional partners into the Partnership.
	 	 	 
	 	17.3.	The
    opening of accounts at financial institutions.
	 	 	 
	 	17.4.	Approval
    of the annual business plan and the investment plan.
	 	 	 
	 	17.5.	Approval
    of distribution or non-distribution of dividend.
	 	 	 
	 	17.6.	Approval
    of any transaction between parties at interest, including amendments to transactions between parties at interest.
	 	17.7.	The
    granting of guarantees to third parties.
	 	 	 
	 	17.8.	The
    obtaining of loans and/or investment capital.
	 	 	 
	 	17.9.	Entry
    into new fields of activity.
	 	 	 
	 	17.10.	Activity
    with a material impact on the lifestyle at Beit Ha’Emek .
	 	 	 
	 	17.11.	Signatory
    rights.
	 	 	 
	 	17.12.	Appointment
    of CEO and chairman.

 

	18.	The
    Partnership will appoint a manager for the Farm as shall be needed, who shall be responsible for the employees of the Farm and the
    routine operations of the Farm and everything related to the Cultivation at the Farm. The parties agree that Canndoc has a first
    right to propose a candidate on its behalf for this position, in light of its expertise and multi-year experience in the field.

 

Accounting

 

	19.	It
    is agreed between the parties that the accounting services of Canndoc will be conducted at the accounting department at Beit Ha’Emek
    in accordance with customary and agreed market prices. The accounting of the Partnership will be conducted in the books of Canndoc,
    separately from the remainder of its financial activity which is not related to the Partnership, as activity-based-costing activity
    (hereinafter: “the Ledger of the Partnership”). All of the data in the Ledger of the Partnership will be available
    for review of any party at any time. It is clarified that this service includes payroll accounting services and costing services
    for analysis of the operations. All of this, at competitive prices which shall be approved by the management of Canndoc.
	 	 
	 	Accounting
    services include: preparation of monthly/quarterly/annual reports, payroll accounting, costing services for detailed analysis of
    the products or sub-activities, preparation of a balance sheet.

 

    	 

     

    

 

	20.	The
    management of the Partnership will receive a report every quarter concerning the income and expenses of the Partnership, and any
    other information required in connection with the Partnership and its business affairs.
	 	 
	21.	The
    books of account of the Partnership shall be open at all times to the parties to this agreement. Canndoc shall be exclusively liable
    shall have discretion for performance of current payments on behalf of the Partnership.

 

Financing,
investments and expenses

 

	22.	The
    income of the Partnership will serve for payment of its current expenses.
	 	 
	23.	To
    such extent as the Partnership shall require financing for its activity, including its current activity and/or its expenses and/or
    compliance with its undertakings pursuant to this agreement and/or for its debt upon liquidation, such financing will be provided
    by each party, in accordance with its proportional share in the holding of the Partnership.
	 	 
	24.	In
    the event that the Association shall be unable to provide the funds required for purposes of the Investment in the Partnership and/or
    financing of its current and/or other activity and/or bearing of its expenses and/or compliance with its undertakings and/or any
    other monetary undertaking pursuant to this agreement (hereinafter: “the Investment”), the Association shall find
    a party to provide a loan to the Association at the rate of the Investment required at such time in the stead of the Association,
    on behalf of the share of the Association, alongside the share of Canndoc as stated. In the event that Canndoc shall be the party
    to provide the loan to the Association, then the loan shall be returned to Canndoc from the share of the Association in the profit
    of the Partnership. The loan shall be provided under terms of a commercial market loan at such time, which shall be concluded between
    the parties in advance and in writing. Every Investment invested by any of the parties in the Partnership in accordance with the
    business plan and in accordance with the investment plan, and subject to that stated in this agreement and in accordance with applicable
    law, and to such extent as the resolution for investment has been passed lawfully by the competent organs of the Partnership, including
    financing of the current activity and/or bearing of expenses in which the Partnership must bear, shall be deemed as a shareholder’s
    loan which shall be returned to the parties prior to distribution of profit to the parties to such extent as there shall be any.

 

    	 

     

    

 

	25.	Shareholder’s
    loans shall bear annual interest at a rate which shall be determined on the date of provision of each and every loan.

 

Payments
and expenses

 

	26.	The
    parties in the Partnership will bear the current expenses arising from the operation of the Farm and the Cultivation in accordance
    with the rate of their holding in the Partnership and in accordance with the requirements of the regulator and/or any other necessary
    institution. To such extent as yields shall be made in the Property for activity of Canndoc which is not in the framework of the
    Cultivation, the expenses of this activity shall not apply to the Partnership.
	 	 
	27.	Use
    of water by the Partnership shall be made in accordance with applicable law.
	 	 
	28.	Payment
    on behalf of water consumption shall be paid on a current basis by the Partnership to the water provider in accordance with the water
    tariffs determined in the Potable Water for Agriculture Law, and which are published by the Water Authority.
	 	 
	29.	The
    Partnership shall endeavor, immediately after the signature upon this agreement, to obtain an agricultural water quota from the Water
    Authority in accordance with the anticipated consumption for the venture. The Kibbutz undertakes to reasonably endeavor that the
    Partnership shall be entitled to the water quota and that the provision of water to the Partnership shall be regular and uninterrupted.
	 	 
	30.	Employees
    of Canndoc will provide work services to the Partnership. The aforementioned employees shall be employed by Canndoc. The Kibbutz
    shall have a first right to propose employees to Canndoc for work in the Partnership under salary terms which are customary at Canndoc
    and at law, and who shall be qualified to carry out the work which is required. Acceptance of Employees is contingent upon the approval
    of the management of the Partnership and all of the required institutions (the Police, the Ministry of Health, and so forth). The
    Partnership of the management has full liberty to employ and/or dismiss employees as it deems fit, from the Kibbutz and/or from any
    other source.

    	 

     

    

 

	31.	For
    the sake of removal of doubt, the Partnership is not responsible for the rights of employees in the period preceding the establishment
    of the Partnership. Each party undertakes to indemnify the Partnership and/or the counterparty in respect of lawsuits of members
    and salaried employees who worked at such party, and were transferred to work in the Partnership, if these shall sue the Partnership
    in respect of the period preceding its establishment, or in respect of their work other than in the framework thereof. Attached hereto
    as Appendix E concerning employees who we employed by the parties prior to establishment of the Partnership.
	 	 
	32.	The
    Partnership will pay the electrical and gas and/or any other expense required for purposes of the use and the Cultivation.

 

Profit
and loss

 

	33.	Profit
    will be distributed solely and exclusively after performance of all the payments in respect of the current expenses required for
    management of the business affairs of the Partnership, the Investments, payment of all of the financing expenses (in accordance with
    this order).
	 	 
	34.	All
    of the expenses and taxes will be paid in practice by Canndoc since the Partnership will be activity-based-costed at Canndoc and
    Canndoc will obligate the Partnership. From the profit available for distribution, the amounts for return of Investment shall initially
    be deducted. Investments, to such extent as shall be required, shall be approved in advance and in writing by both parties. If an
    agreed Investment shall take place, where Canndoc will provide the financing thereof with the approval of the Association, the financing
    and the principal shall be set off in the pricing, prior to calculation of the profit for distribution.
	 	 
	 	When
    profits shall be distributed in the activity-based-costing partnership, it shall be distributed in accordance with the ownership
    70% - 30%. In any event, the Association shall be entitled to 30% of the pricing profits.

 

    	 

     

    

 

The
Property

 

	35.	The
    Kibbutz declares and undertakes hereby as follows:

 

	 	35.1.	It
    is the holder of a lease-right in the Property pursuant to a lease contract signed with the Israel Lands Administration on 26.4.1990,
    for a period commencing on 1.10.1989 and ending on 30.9.2038, save for a change, if and to such extent as shall apply, in light of
    the change in the classification of Beit Ha’Emek to a town. To such extent as the Kibbutz is aware, this change is not anticipated
    to impact that stated in the agreement. If it shall have a detrimental effect - the right to exit the agreement shall be in accordance
    with the provisions set forth in clause 50.
	 	 	 
	 	 	The
    lease agreement with Israel Lands Administration is attached as Appendix F of this agreement.
	 	 	 
	 	35.2.	 That
    on the date of the signature upon this agreement, it is not aware of any bar to renewal of the lease agreement with the Israel Lands
    Administration, for any period.
	 	 	 
	 	35.3.	That
    to such extent as is contingent upon it, it shall continue to remain the lessee and the holder of the Property throughout the entire
    period of this agreement, and shall not grant or assign or transfer or pledge its rights in the Property to any third-party (save
    for the Association) and shall not carry out any action which may prevent renewal of the lease agreement with the Israel Lands Administration
    at the end of any lease period. The Kibbutz undertakes to endeavor with the Israel Lands Administration to extend/renew the lease
    agreement including the Property, which shall ensure its rights in the Property for the entirety of the duration of this agreement.
    For the sake of removal of doubt, it is clarified hereby that to such extent as an agreement shall not be signed with the Authority
    for reasons not contingent upon the Kibbutz, this shall not be deemed breach of the agreement, and Canndoc and/or the Partnership
    shall not be entitled to any additional compensation in respect thereof. In such instance, Canndoc shall be entitled to notify upon
    cessation of the engagement immediately, and the Association and the Kibbutz shall not be entitled to any compensation in connection
    therewith.

 

    	 

     

    

 

	 	35.4.	All
    of its rights in the Property are free of any pledge or any other third-party right.
	 	 	 
	 	35.5.	That
    subject to receipt of the approvals required from the competent Authority, pursuant to the Agricultural Settlement Law and/or pursuant
    to the lease contract with the Israel Lands Administration, there is no statutory, legal, contractual, or other bar to its engagement
    in this agreement and fulfillment of its undertakings hereunder.
	 	 	 
	 	35.6.	The
    Kibbutz and/or the Association will grant the Partnership authorization to use the Property subject to the approval of the Ministry
    of Agriculture and/or a party on its behalf.
	 	 	 
	 	35.7.	The
    declarations of the Association above, and their accuracy, are a fundamental condition to the signature upon this agreement.

 

	36.	The
    Kibbutz and Beit Ha’Emek Agriculture undertake hereby as follows:

 

	 	36.1.	Subject
    to that stated above, to provide the Property as defined in the preamble to this agreement for the use of the Partnership throughout
    the entire period of this agreement, without consideration, for every purpose related to the Cultivation of medical
    cannabis as defined in this agreement, and for such purpose alone and subject to that stated in this agreement.
	 	 	 
	 	36.2.	To
    pay in respect of the Property, throughout the entire period of the agreement, lease/rental fees to the Israel Lands Administration,
    in the framework of the annual payments to the Authority carried out by the Kibbutz in respect of the Kibbutz square, and to make
    available the Property when it is clear of any person and waste.
	 	 	 
	 	36.3.	To
    bear any payment which shall be imposed upon the Property and which is imposed upon the owner and/or the lessee of the Property.

 

    	 

     

    

 

	 	36.4.	Not
    to endeavor and/or to initiate a change in the zoning of the Property to any other zoning (including residential and/or industrial)
    in such manner as shall harm the use of the Property in accordance with this agreement, and save for existing plans.

 

	37.	The
    Partnership shall bear any payment imposed upon the Association/Kibbutz in respect of the activity of the Partnership in the Property
    and which is imposed upon the holder (as distinct from the lessee/owner) of the Property, including payment of municipal taxes to
    the Mateh Asher Regional Authority, and other taxes as shall be required, and provided that they apply by their nature to the holder
    and user of the Property and not to the owner thereof or the lessee in the Property.
	 	 
	38.	It
    is clarified and agreed that other than the right of use granted to the Partnership pursuant to this agreement, there is not and
    shall not be any right in the Property for the Partnership.
	 	 
	39.	The
    Partnership will not carry out any planning changes and/or changes in zoning, unless agreed otherwise in writing, and after the rules
    related to the financial investments and the rights of the parties shall have been determined.
	 	 
	40.	The
    Partnership shall not carry out any structural changes to the contour, improvement in the Property, drainage, and changes in the
    outline of the Property other than changes required for the current Cultivation, beyond the Areas of the Property,
    unless this was agreed in advance and in writing, and after the rules related to the monetary investments and the rights of the parties
    shall have been determined. That stated shall not apply to any changes in the existing structures today.
	 	 
	41.	It
    is agreed hereby that at the end of the period of the right of use as stated in this clause, the Kibbutz/Beit Ha’Emek Agriculture,
    have the right to demand of the Partnership to remove all of the construction and the infrastructure installed which may not be separated
    or dismantled by the Partnership, or to leave them in the land, all at its discretion and without being required to pay any compensation
    in respect of the infrastructure. The Kibbutz/Beit Ha’Emek Agriculture will participate in the costs of the removal in accordance
    with the rate of its holdings in the Partnership.

 

    	 

     

    

 

Provision
of the Property to the Partnership

 

	42.	Beit
    Ha’Emek Agriculture/the Kibbutz undertake to provide the Property for the use of the Partnership from the date of the provision
    of the approval of the competent Authority pursuant to the Settlement Law.
	 	 
	43.	If
    60 days have passed from the signature upon this agreement and the approval of the Supervisor pursuant to the Agricultural Settlement
    Law has not been issued for the activity of the Partnership in the Property, each party shall be entitled to cancel this agreement
    without this being deemed breach and without any of the parties being obligated in compensation to its counterpart.
	 	 
	44.	Nothing
    in that stated above shall detract from the obligation of all of the parties to diligently and in good faith endeavor to obtain the
    approval.
	 	 
	45.	The
    Property will be delivered to the Partnership in its condition at the time of its delivery (As Is), and the Partnership shall have
    no contention with respect to the type, nature and/or condition of the Property, upon all of the connections thereto, and included
    with respect to electricity, water, and sewage infrastructure, save for a hidden fault and/or defect.
	 	 
	46.	The
    Partnership will use the Property for every purpose in the field of Cultivation of medical cannabis and extraction of medical cannabis
    into oil (hereinafter: “the Product”), pursuant and subject to all of the relevant licenses and/or permits in
    accordance with applicable law and/or directive of any competent Authority throughout the entire period of the authorization, and
    which are valid, and the sale of the Products to Canndoc, which is responsible for the transportation and distribution of the Product
    to its patients.

 

The
period of the agreement for the authorization for use of the Property

 

	47.	The
    period of authorization of use of the Partnership in the Property shall be 5 years + 3 options of 5 years each which shall be renewed
    automatically subject to fulfillment of all of that stated in this agreement.

 

    	 

     

    

 

	48.	Upon
    liquidation of the Partnership, the following shall apply:

 

	 	48.1.	The
    Partnership shall vacate the agricultural lands and return them to the Kibbutz.
	 	 	 
	 	48.2.	The
    Partnership will cover all of its expenses and liabilities as of the date of the liquidation.
	 	 	 
	 	48.3.	To
    such extent as a profit balance shall remain for the Partnership (which was collected in practice), and after coverage of all of
    the debts and liabilities, then the profit balance shall be divided between the partners in accordance with their share in the division
    of profit.

 

Cancellation
of the agreement

 

Cancellation
of the agreement by Canndoc

 

	49.	In
    any instance where the grower’s license of Canndoc will be suspended or frozen and/or any decision of the government and/or
    any other body shall be passed whereby the Cultivation of medical cannabis in Israel shall be prohibited or new regulations or regulatory
    requirements shall enter into force and/or the grower’s license of Canndoc shall not be renewed, Canndoc shall be entitled
    to notify the Association of termination of the Partnership and the expiry of this agreement immediately, and without any of the
    parties having any contention and/or demand and/or claim in respect thereof.
	 	 
	50.	It
    is clarified that in the event of a detrimental material change (exceeding 10%) in the price paid by a patient for a gram of medical
    cannabis and/or cannabis oil, Canndoc shall be entitled to notify the Association of cessation of the activity of the Partnership
    and expiry of this agreement immediately, and without any of the parties having any contention and/or demand and/or claim in respect
    thereof.
	 	 
	51.	Canndoc
    shall be entitled to notify the Association at any time upon liquidation of the Partnership and termination of this agreement, by
    advance notice 3 (three) months in advance. If Canndoc shall have cancelled the agreement as stated in this clause, other than due
    to its breach by the Association, the following provisions shall apply:

 

    	 

     

    

 

	 	51.1.	The
    Partnership will vacate the property within two months from the date of the notice of termination of this agreement.
	 	 	 
	 	51.2.	Upon
    vacating the Property, the Association and/or the Kibbutz and/or Canndoc shall have no contention and/or demand and/or claim toward
    the other parties and/or the Partnership concerning cancellation of the agreement subject to that stated above.

 

	52.	In
    the instances stated above in clauses 49-50, everything existing in the Property and connected thereto permanently, including the
    infrastructure and the structures, shall remain in the Kibbutz and shall belong to the Kibbutz, without any payment on behalf of
    the Kibbutz.
	 	 
	 	The
    Kibbutz will be entitled to receive from the partners its proportional share in the equipment and the investments acquired after
    foundation of the Partnership, after deduction of any investment made by Canndoc in the Partnership in respect of the share of the
    Association or the Kibbutz as stated in clause 24 of the agreement and after depreciation.
	 	 
	 	In
    the event where the agreement was cancelled pursuant to the provisions of clause 51 only, the Association will be entitled
    also to liquidated damages in an amount of NIS 200,000. With respect to other equipment in the property, to such extent that the
    Kibbutz shall deem it relevant for its uses, it shall be delivered for the use of the Kibbutz on account of such compensation, in
    accordance with its book value. The remainder of the compensation will be paid by Canndoc in cash within a period of 90 days from
    the date of the notice of the cancellation, with deduction of any income invested by Canndoc in the Partnership in respect of the
    share of the Association or the Kibbutz as specified in clause 24 of the agreement. The Kibbutz may withhold the equipment only as
    collateral for the performance of the payment by Canndoc. The Kibbutz and/or the Association shall not be entitled to maintain possession
    of an inventory of medical cannabis and/or its products, documents, funds, and so forth.

 

    	 

     

    

 

Cancellation
of the agreement by the Association and by the Kibbutz

 

	53.	The
    Association shall be entitled to cancel this agreement by notice of 18 months in advance or until Canndoc shall locate an alternative
    Cultivation area approved by the required Authority, the earlier of these, as well as in any instance where continued performance
    of this agreement is not possible subsequent to a demand of any Authority to terminate it, and provided that the Association did
    not initiate, in any manner, whether directly or indirectly, the approach to the Authority, and it carried out every action required
    and operated diligently in order to remove the aforementioned demand. Notwithstanding that stated, a demand of any Authority which
    cannot be fulfilled without any expenditure by the parties (save for payment, as shall be required for renewal of the square contract
    (the lease contract of the Kibbutz) with the Israel Land Authority) shall not constitute a demand which brings about the end of the
    agreement as stated above, and the parties will collaborate, to such extent as possible, in fulfillment of the demand, and all in
    accordance with the circumstances of the matter. “Any authority” - for purposes of this clause - including the Israel
    Land Authority, Ministry of Agriculture, Supervisor of exercise of the Agricultural Settlement Law, the relevant planning and building
    committees, the regional council and so forth.
	 	 
	54.	If
    the Association has cancelled the agreement due to a demand of such Authority above, Canndoc shall be entitled to take possession
    of any equipment and/or installation and/or attachments acquired as part of the joint activity, at its discretion, and provided that
    it shall return the area of the Farm in a clean and orderly manner to the Association/Kibbutz, and this is against a refund of payments
    to the Association in respect of the proportional share of the Association in the equipment, to such extent as it has invested funds
    in the equipment and with deduction of any investment by Canndoc in the Partnership in respect of the share of the Association or
    the Kibbutz as stated in clause 24 of the agreement.

 

    	 

     

    

 

Prohibition
on competition

 

	55.	The
    Association and/or the Kibbutz, their managers and shareholders therein, undertake not to compete with the business of Canndoc Ltd.
    and/or the business of the Partnership, directly or indirectly, themselves and/or by means of others, whether independently or as
    salaried employees, including by way of partnership or of holding, themselves or through others, in shares or in management rights
    in any corporations, in Israel and/or overseas, for five years from the expiry of this agreement for any purpose whatsoever. 

 

Preservation
of confidentiality

 

	56.	Throughout
    the period of this agreement, and thereafter, the Association and/or the Kibbutz and their managers, undertake not to disclose and/or
    transfer to any person and/or entity, information upon Canndoc and/or Canndoc Ltd. and/or the business and activity of the Partnership
    or information and/or a list of customers and/or suppliers and/or Cultivation protocols, irrigation regimes, fertilizer and aeration
    and/or any other information related to the intellectual property (hereinafter: “the Information”) which has reached
    it in the framework of the period of the Partnership and/or in connection with Canndoc and/or Canndoc Ltd. and/or the Partnership.
    The Association and/or the Kibbutz and their managers undertake to preserve in confidence everything related to the business affairs
    of Canndoc and/or Canndoc Ltd. and/or the Partnership, and not to harm in any manner the goodwill of Canndoc and/or Canndoc Ltd.
    and/or the Partnership and/or their customer database.
	 	 
	57.	The
    Association and/or the Kibbutz and their managers undertake to maintain absolute confidentiality in connection with all of the Information
    as defined above and/or know-how and/or confidential information and/or any other information of value and/or of any third-party
    maintaining connections with Canndoc, Canndoc Ltd. and the Partnership, and which reached them subsequent to their connection with
    Canndoc and/or Canndoc Ltd. and/or the Partnership (hereinafter: “the Additional Information”).
	 	 
	58.	The
    Association and/or the Kibbutz and their managers undertake not to make any use of the Information and/or the confidential information
    and/or the Additional Information without express consent in writing from Canndoc Ltd., whether themselves, or by means of others,
    whether directly or indirectly, and not to transfer same to any person and/or corporation for any purpose whatsoever, whether for
    consideration or without consideration.

 

    	 

     

    

 

	59.	The
    provisions of this clause shall apply indefinitely, even this agreement shall be cancelled for any reason whatsoever.

 

Intellectual
property

 

	60.	It
    is clarified and agreed between the parties expressly that all of the current and future intellectual property rights in the intellectual
    property upon all of its components, including, but not only, types of strains, methods for extraction of oil, types of oils, Cultivation
    protocols, patient lists, contact persons at various Authorities, and commercial secrets (hereinafter: “the Intellectual
    Property”) are the exclusive property of Canndoc. Furthermore, the Association and/or the Kibbutz and their managers and/or
    any party on their behalf are prohibited from using the Intellectual Property for any purpose other than in accordance with the provisions
    of this agreement and/or after the conclusion of this agreement for any reason whatsoever.
	 	 
	61.	The
    Intellectual Property is a commercial secret owned exclusively by Canndoc, which was obtained by great investment and extensive efforts,
    and the Association and/or the Kibbutz and/or their managers and/or a party on their behalf shall have no contention in connection
    with the eligibility of the Intellectual Property to constitute a commercial secret, and that the use thereof shall be made pursuant
    to this agreement, and that they shall not contend ownership or a right in connection with the Intellectual Property.

 

Compensation
and grants

 

	62.	To
    such extent as during the period of disagreement, an insurance and/or security and/or war and/or natural disaster event shall take
    place, as a result of which the cannabis plants and/or the Products derived from them and/or the equipment and/or the inventory of
    the Partnership shall be occasioned damage which entitles and/or may entitle any of the parties in this agreement to compensation
    and/or proceeds whatsoever from an insurance company and/or the fund for natural damage or any other entity, the compensation and/or
    the proceeds to the Partnership shall belong to the Partnership and the party who has received them undertakes to transfer them to
    the Partnership, and this in connection with the crops and/or the Product which had begun and/or been created after the signature
    upon this agreement.

 

    	 

     

    

 

	63.	To
    such extent as the Association shall be able to receive grants in respect of investments in Cultivation and/or processing, irrigation
    systems and/or drainage and ground preservation works, from the Ministry of Agriculture or from any other entity, the Association
    shall endeavor to submit applications and to receive the grants, and the grant will be transferred to the Partnership. For the sake
    of removal of doubt it is clarified that the transfer of such grants to the Partnership shall not be deemed a loan and/or investment
    of the Association in the Partnership.

 

Liability
and insurance

 

	64.	It
    is emphasized that the Partnership will engage solely and exclusively in Cultivation as defined in this agreement. All of the activity
    and all of the liability for the activity carried out prior to the Cultivation and/or thereafter, such as: development of strains,
    and activity which shall be carried out at the end of the Cultivation such as: marketing to patients, liability for products from
    the moment they were delivered to Canndoc and so forth, shall not apply to the Partnership and/or the Association and/or the Kibbutz
    and/or any party on their behalf. The Partnership between the parties is for purposes of Cultivation alone.
	 	 
	65.	It
    is clarified that the Partnership will not bear any direct or indirect liability for the products of Canndoc which are marketed to
    the patients and/or to any other party and any other liability for matters which are not related to the process of Cultivation. The
    exclusive liability for this matter shall be that of Canndoc and it shall indemnify the Association and/or Beit Ha’Emek in
    the event where a lawsuit and/or a demand shall be submitted against them in respect of the Product of Canndoc Ltd., and a judgement
    shall be issued, subject to that stated in this agreement.

 

    	 

     

    

 

	66.	The
    Partnership will finance the cost of product liability insurance with an insurer, and it undertakes to indemnify the parties to this
    agreement in the event that a lawsuit and/or demand shall be submitted against them in respect of the Product.
	 	 
	67.	The
    Partnership/Canndoc will insure its activity in accordance with and subject to the provisions of this agreement with the following
    insurance policies: product liability insurance, third-party liability insurance, employers liability insurance, these insurances
    will include the parties to this agreement and the Kibbutz as insured parties.
	 	 
	68.	The
    Partnership will act to insure its operations in product liability insurance as stated in this agreement. In any event, all of the
    liability for the Product and its marketing, from the moment of its delivery to it, shall apply to Canndoc Ltd. alone, subject to
    the remainder of the provisions of this agreement.
	 	 
	 	Attached
    hereto is an insurance appendix describing the insurance policies to apply to the Partnership and the insurance policies to be affected
    by Canndoc.

 

Suspending
condition

 

	69.	The
    validity of this agreement is contingent upon receipt of the consent of the competent Authority pursuant to the Agricultural Settlement
    Law (exceptions to use in land and water) - 1967 and the routine operations pursuant to this agreement. The Association and Canndoc
    undertake, immediately after the signature upon this agreement, to seek the consent of the competent Authority pursuant to the Agricultural
    Settlement Law and to endeavor diligently and in good faith to obtain such approval.
	 	 
	70.	The
    Association and Canndoc undertake to act in every possible manner for approval of this agreement, including submission of legal actions
    and appeals and/or reservations to every necessary legal forum.
	 	 
	71.	The
    Kibbutz undertakes to endeavor to assist in any possible manner for obtaining of such approval.

 

    	 

     

    

 

	72.	The
    validity of this agreement is contingent upon the approval of the competent Authority in the Kibbutz for the engagement.

 

The
Relations of the parties

 

	73.	For
    the sake of removal of doubt, the existence of the Partnership shall not limit the parties in any manner or form in the conduct of
    their business or their assets during the period of the agreement, save as determined expressly in this agreement, and it does not
    have the effect of restricting the parties in any manner whatsoever after the period of the agreement, subject to the provisions
    of this agreement.
	 	 
	74.	Subject
    to the advance approval of the head of the medical cannabis unit in the Ministry of Health, Canndoc shall be entitled to bring into
    the Farm for purposes of a visit and a review, any relevant entity, including research and development parties, investors, performing
    contractors for infrastructure work, maintenance and their employees.
	 	 
	75.	It
    is clarified that the Association and/or the Kibbutz shall not be entitled to bring any party on their behalf into the bounds of
    the Farm without the approval of Canndoc and the approvals required from the medical cannabis unit at the Ministry of Heath and the
    Israel Police.

 

Transfer
of duties and rights

 

	76.	The
    parties shall not be entitled to assign the rights and obligations under this agreement in any manner whatsoever, including by way
    of sale and/or release and/or pledge, save for assignment to a corporation which is exclusively controlled by the assigning party
    or of Kibbutz Beit Ha’Emek. However, the parties shall be entitled to carry out a change in the holdings therein per their
    desire and freely, and provided that this shall not prejudice any provision and/or directive in this agreement.

 

    	 

     

    

 

Miscellaneous

 

	77.	Any
    change and/or amendment and/or reduction and/or appendix and/or additional agreement related to this agreement shall be made in writing
    only and signed by the parties. 
	 	 
	78.	The
    addresses of the parties shall be as indicated in the headings of this agreement and any postal items sent by registered post to
    the aforementioned address shall be deemed to have arrived to its destination within three business days from the date of the dispatch.

 

	In
    witness whereof the parties have signed
	 	 	 
	Canndoc
    Ltd.	 	the
    Association (new association)

 

	 	 	 
	Beit Ha’Emek Agriculture - Cooperative Agricultural Association Ltd.

 

	 	 	 
	Kibbutz
    Beit Ha’Emek Agriculture - Cooperative Agricultural Association Ltd.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}]]